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Abstract 
The smallest contractile unit within striated muscle cells are called sarcomeres.  The 
boundary regions between sarcomeres are called Z-discs, which contain over 30 
different proteins, organised within a narrow ~100 nm wide structure. Standard 
fluorescence microscopy approaches do not reveal the arrangement of Z-disc proteins, 
as the width of the Z-disc is below the resolution limit (~250 nm).  The arrangement of 
the actin filaments and the cross-linking proteins α-actinin in the Z-discs are well 
characterised by electron microscopy (EM) studies, however other Z-disc proteins are 
not. With the development of super-resolution fluorescence microscopy techniques, it is 
now possible to obtain Z-disc protein localisation information. Here, dSTORM (direct 
Stochastic Optical Reconstruction Microscopy) was used, to investigate the 
arrangement of α–actinins in Z-discs of cardiomyocytes, and then the arrangement of 
the N-terminal ends of the giant protein titin in the Z-discs. Affimers were generated to 
bind α–actinin 2 and the N-terminal titin domains (Z1/Z2), to use as binders in 
dSTORM. Affimers are small (~12 kDa) non-antibody binding proteins, about 1/10th the 
size of antibodies, that can be selected to bind to a specific protein. The localisation 
data of dSTORM using the Affimer binders showed the same regular arrangement of α-
actinins observed in EM studies. The use of dSTORM with Affimers also suggests the 
titin Z1/Z2 domains do not only localise at the edges of the Z-discs but arranged 
throughout the Z-disc with regular spacing (~25 nm) in the transverse plane of the Z-
discs.  
Also, three mutations located in the actin binding domain of α-actinin 2 associated to 
hypertrophic cardiomyocytes (G111V, A119T and M228T) were characterised by in 
vitro co-sedimentation assays with actin. The mutants G111V and A119T did not show 
a significant difference in binding affinity to actin compared to the wild-type. The co-
sedimentation assays did however suggest the mutation M228T significantly increases 
the binding affinity of α–actinin 2. 
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Chapter 1 - Introduction 
1.1 Sarcomeres and Z-discs 
Cardiac and skeletal striated muscle cells have highly ordered cytoskeletons with 
bundles of myofibrils running the length of the cells. Each myofibril is composed of 
repeating units of sarcomeres, the smallest contractile unit within striated muscle cells. 
The repeat, parallel order of the sarcomere units within the myofibrils allows for 
contraction and relaxation of the cells. The basic structure of a sarcomere can be 
described as a repeat array of inter- laying thick myosin motor filaments and thin actin 
filaments (Figure 1.1). Distinct lateral regions have been observed within sarcomeres 
by electron microscopy; the Z-disc, I-band, A-band and the M-line. The Z-discs, Z-
bands or Z-lines are observed as dense boundary regions between sarcomeres. These 
boundary regions form highly complex network of proteins, which needs to maintain 
structural stability during contraction and transmission of force between sarcomeres. 
Also, major signalling pathways are thought to occur in the Z-discs (reviewed in Frank 
and Frey 2011). The thick myosin filaments extend the A-band region and are not 
present in the I-bands or the Z-discs (Figure 1.1).  Filamentous actin, the major 
component of the thin filaments extends from the Z-discs through into the A-band. 
Within the Z-discs the barbed ends of the actin filaments are stabilised by the actin 
capping protein CapZ (Schafer et al. 1995). Actin filaments from adjacent sarcomeres 
meet at the Z-disc and are cross linked via α-actinins (Figure 1.1), thus the Z-discs are 
commonly described as the anchoring points between sarcomeres.  
The giant proteins nebulin and titin are also integral players within the sarcomere 
cytoskeleton. Titin (~3 MDa), spans half the sarcomere starting in the Z-disc and 
ending at the M-line (Labeit et al. 1995, Figure 1.1). Titin in the A-band is composed 
of a super repeat pattern of four immunoglobulin-like domains and seven fibronectin 
type 3 domains and interacts with the thick filaments via myosin binding protein C and 
the myosin tail (Houmeida et al. 1995, Labeit et al. 1995 Freiburg et al. 1996). Titin 
in the I-band has been termed a molecular spring due to repeat PEKV domains which 
have elastic properties (Linke et al. 1998, 1999). The N-terminal end of titin (~ 60 kDa) 
is within the Z-disc region (Gregorio et al. 1998), The N-terminus of titin (residues 1-
200) is composed of two Ig-like domains, the Z1/Z2 domains. The Z1/Z2 domains from 
two different titin molecules are thought to be cross-linked by the small protein 
telethonin (19 kDa) at the periphery of the Z-discs (Mues et al. 1998, Zou et al. 2006). 
Analysis of the primary sequence from human cardiac titin has shown seven short 45 
residue Z-repeat domains are present in the Z-discs, that have been proposed to act as 
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a scaffold for the α-actinins (Gautel et al. 1996, Sorimachi et al. 1997). 
Nebulin (~ 800 kDa) extend the length of the actin filaments and is composed of ~185  
α-helical repeat domains (35 residue, M-domains) (Labeit et al. 1995), which interact 
each with actin.  Vertebrate cardiac muscle only exhibits low level expression of 
nebulin (Kazmierski et al. 2003). However, cardiac muscle also expressed a smaller 
homologue, nebulette (~ 100 kDa), which has twenty-three M-domains and is only 
present within the Z-discs and extends into the I-band (Moncman et al.1995, Millevoi 
et al. 1998), Within the Z-discs nebulin/nebulette have highly conserved domains at the 
C-terminal end; a Src homology 3 domain (SH3) domain and a linker region (Labeit et 
al. 1995). From the position of known binding partners (Pappas et al. 2008, Ma et al. 
2002, Bang et al. 2002) a model has been put forward where the C-terminal domain is 
at the periphery of the Z-discs by single nebulin molecules extending fully into the Z-
disc region and crossing actin filaments from adjacent sarcomeres (Pappas et al. 
2008) (Figure 1.1).   
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1.2 Viewing Z-discs by electron microscopy (EM)  
The protein dense Z-disc structure within striated muscle has been commonly studied 
by electron microscopy (EM). The Z-discs are seen as dense regions between 
sarcomeres in longitudinal views of striated muscle sections. A distinct zig-zag pattern 
can also be seen in the Z-discs, which are thought to be links between the actin 
filaments in the Z-disc. The width of Z-discs and the number of zig-zag layers vary 
depending on the muscles type. Both cardiac and skeletal slow muscle have wide Z-
discs (100-140 nm, Luther et al. 2003) and three zig-zag layers are present spaced ~ 
38 nm apart.  
Viewing transverse sections of striated muscle by EM have shown the Z-discs to have 
an ordered lattice structure. Two different conformations within the Z-discs of muscle 
tissues have been observed; the small square lattice (Figure 1.2A) and the basket 
weave (Figure 1.2B). A mixture of the two conformations are commonly seen in 
muscle samples by EM. These two distinct conformations were also observed by X-ray 
diffraction in rabbit psoas muscle (Prez-Edwards et al. 2011). In the same study under 
relaxed conditions, 89 % of the Z-disc lattice was thought to be small square. Under 
tension the small square conformation was reduced to 36 %. This study suggests both 
conformations are present in the Z-discs no matter the conditions, however the ratio 
between the conformations change.   
The lattice spacing (the distances between actin filaments from the same sarcomere) 
has been reported for many different muscle types. The lattice spacing in the Z-discs of 
rat papillary muscle was initially proposed to be at ~ 20 nm for the small square lattice 
conformation (Goldstein et al. 1989). This is consistent with to the lattice spacing of 
skeletal muscle reported at a similar time (Goldstein et al. 1986). In a more recent 
study however, the lattice spacing was found to be ~ 30 nm (Burgoyne et. al 2015). 
The reason for this 50 % increase compared to initial reports is unclear. The lattice 
spacing for the basket weave conformation in cardiac muscle has also been reported to 
be 24 nm, a 20 % increase upon the small square (Goldstein et al. 1989). More 
recently, only an 8 % increase in lattice spacing from the small square to the basket 
weave conformations of rabbit psoas muscle was observed (Prez-Edwards et al. 
2011). This is a much smaller increase than for cardiac muscle reported, however the 
discrepancy could be explained by the different muscle samples used.  
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1.2.1 3D models of the Z-disc 
Via electron microscopy techniques, 3D density maps of Z-discs in different 
conformations and from different muscle types have been generated. Actin filament 
rods and α-actinin cross-links between the filaments have been fitted into these density 
maps. A 3D model was generated by EM for the Z-disc structure of nemaline rods 
(Figure 1.2C, Morris et al. 1990). Nemaline rod structures are found in the skeletal 
muscle cells of patients with nemaline myopathy, a congenital disease which causes 
muscle weakness (Sewry and Wallgren-Pettersson 2017). Nemaline rods have 
distinctly larger Z-discs (1 -2 µm in width) than normal Z-discs (~ 50 -140 nm in width) 
and lattice conformation is very similar to that of the small square lattice, when viewed 
by EM.  In this model the rod domains of the α-actinin homodimers are parallel to the 
actin filaments. Two separate α-actinin molecules are found close together on the 
same actin filament linking different actin filaments from the neighboring sarcomere. 
They are separated by an axial rise of 2.74 nm (a single G-actin subunit) and are 
orientated differently on the actin filament by 167.4. The α-actinins bound are 
proposed to follow the 43  screw symmetry of the actin filament.  Each pair of α-actinins 
are arranged regularly along the actin filament, spaced 19.2 nm apart and rotated 90  
from each other (equivalent to every seventh G-actin subunit).   
Most recently electron tomography with sub-tomographic averaging has been used to 
study the small square lattice structure within the Z-discs of rat papillary muscle 
(Burgoyne et al. 2015). In this study a density map of the small square lattice with 
three layers of α-actinin molecules was obtained to a resolution of 8 nm. The Morris et. 
al model for nemaline rods was fitted to this density map for the small square lattice. 
Thus far Z-discs have been observed to have 2, 3, 4 and 6 α-actinin layers (Luther 
2009). 3D models of different layered Z-disc in the basket weave conformation have 
been solved from different muscle types and organisms. These included; the Z-disc 
from fish white muscle (two α-actinin layers, Luther 1991), the Z-disc from fish fin 
muscle (three α-actinin layers, Luther 2000) and the Z-disc from bovine neck muscle 
(six α-actinin layers, Luther et al. 2002). In these models the rod domain of the α-
actinins are at a different angle to the actin filaments (Figure 1.2D) thought to be a 
result of the increased lattice spacing of the basket weave to the small square lattice. 
EM studies of the Z-discs have given insights into the conformation the Z-disc lattice 
structure and the arrangement of both the actin filaments and the α-actinin links. 
However, the resolution of the models generated have yet to reach a resolution to fit 
any other Z-disc proteins in the lattice structure.  
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1.3 α-actinin  
1.3.1 The domains of α-actinin  
There are four different human isoforms of α-actinin; the non-muscle ubiquitous 
isoforms 1 and 4 and the muscle isoforms 2 and 3. The four different α-actinin isoforms 
are part of the spectrin superfamily and have a highly conserved primary sequence 
(Sjoblom et al. 2008). The non-muscle α-actinin 1 mainly localizes to focal adhesions 
within cells (Pavalko and Burridge 1991) and α-actinin 4 localizes to membrane 
ruffles in migrating cells (Honda et al. 1998). The muscle isoforms localize to the Z-
discs of striated muscle and where they cross-link the actin filaments. α-actinin 2 and 3 
have a sequence identity of 93 %, however isoform 3 is only expressed in skeletal 
muscle, whilst isoform 2 is expressed in skeletal and cardiac muscle (Beggs et al. 
1992). Thus, α-actinin 2 (103.9 kDa, 894 amino acids) is generally considered the 
dominant muscle isoform. Muscle α-actinin 2, like the other isoforms, is ~ 360 Å in 
length and has three distinct domains; the N-terminal actin binding domain (ABD), the 
central spectrin rod domain and the C-terminal camodulin like (CAM) domain (Figure 
1.3). 
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The N-terminal actin binding domain (ABD) (Figure 1.3) is made up of two calponin 
homology (CH) domains. CH domains are commonly found in the spectrin family 
(Gimona et al. 2002). Each globular CH domain is commonly composed of four large 
α-helices and two smaller α-helices (referred to as α-helices A, B, C, E, F and G). The 
rod domain or spectrin repeat domain of α-actinins is composed of four spectrin 
repeats (SR), extended bundles of three α-helices (Djinovic-Carugo et al. 1999). The 
rod domains of two α-actinin monomers is the main interaction point for the α-actinin 
homodimer and these have a very high affinity for one another (Kd ~ 10 pM) (Flood et 
al. 1995). Crystallographic structures of the rod domain homodimer (Ylanne et al. 
2001, Ribeiro et al. 2014) show a left-handed 90º twist from one end to the other. This 
is key for the ABDs of the α-actinin homodimer to be in the right orientation to crosslink 
actin filaments from adjacent sarcomeres in the Z-disc lattice. The rod domain is also 
thought to be the main interaction point for other Z-disc proteins as many exposed 
negatively charged residues found on the surface of each SR domain (Ylanne et al 
2001). The C-terminal CAM domain comprises of two pairs of calcium insensitive EF 
hands. The EF hand motifs are common helix-loop-helix binding domains. The role of 
the first pair (EF 1-2) of EF hands is unclear, however the second pair (EF 3-4) binds to 
the Z-repeats of titin within the Z-discs (Young and Gautel 2000, Atkinson et al. 
2001). 
1.3.2 Conformation of the N-terminal actin binding domain (ABD) 
The crystallographic structures of the ABD of all the human isoforms of α-actinin 
(Frazot et al. 2005, Borrego-Diaz et al. 2006, Lee et al. 2008, Haywood et al. 2016. 
PDB codes 1WKU,2EYI, 2R0O, 5A36) show two CH domains (CH1 and CH2) in a 
closed compact conformation, with extensive contacts between the domains. The 
structure for α-actinin 2 ABD shows a N-terminal α-helix preceding the CH1 domain 
that had not been resolved in the other isoform structures (Haywood et al. 2016) 
(Figure 1.4A). This N-terminal helix is thought to be flexible. For the CH domains of α-
actinin 2; five α-helices form the CH1 domain (A, C, E, F and G) and six α-helices form 
the CH2 domain (A, B, C, E, F and G) and α-helices A and G of CH1 and the area 
between helices E to G of CH2 form contacts with the opposite CH domain (Figure 
1.4B). Analytical ultra-centrifugation (AUC) of α-actinin 4 suggests the CH1-CH2 
domains are predominantly in the closed conformation when free in solution and crystal 
structure conformations are not crystal packing artefacts (Lee et al. 2008).  The 
residues involved in contacts between CH domains are conserved in all four isoforms. 
At the interface, the majority of the residues form weak hydrogen bonds with the main 
chain of the opposing CH domain. For α-actinin 2 (PDB code 5A36) the residues Q39, 
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K42 and T43 on the α-helix A of CH1 form hydrogen bonds with the main chain of CH2 
(Figure 1.4C). Whilst H254 from CH2 forms a hydrogen bond with the main chain of 
CH1 near the linker loop (Figure 1.4C). The crystal structures of the other α-actinin 
isoforms do not show the equivalent contact between K42 and the CH2 main chain, 
however all the other main chain interactions are conserved.  
There are also direct contacts between residues of opposing CH domains. There is 
direct hydrogen bonding between Q40 (CH1) and D241 (CH2) (Figure 1.4D). The 
crystal structure shown here (PDB code 5A36) shows R53 at the C-terminal end of the 
second helix positioned to form a H-bond with the main chain oxygen of D224 (Figure 
1.4E). In all other ABD crystal structures solved of α-actinin 2 and the other actinin 
isoforms a salt bridge forms between these two residues. This difference suggests 
there is some flexibility in this region. For α-actinin 1, the interaction between the 
residue pair to W128 (CH1) and K236 (CH2) has been suggested to be an important 
interaction at the interface (Borrego-Diaz et al. 2006). This interaction mainly involves 
hydrophobic interactions with occasional π-cation interaction (Crowley and Golovin 
2005) and the residue pair highly conserved in the spectrin family (with the lysine is 
sometimes replaced with either an arginine or glutamine). Muscle α-actinin 2 is the only 
human isoform to have an arginine in place of a lysine in the interaction pair (R243 
(CH2), Figure 1.4F). An arginine near an aromatic side chain is more likely to form a π-
cation interaction compared to lysine (Crowley and Golovin 2005). Therefore, if the 
interaction is important to the stability of the interface, the CH domain interface of α-
actinin 2 should be the most stable of all the isoforms. However, a mutant of α-actinin 4 
with the lysine in the residue pair replaced with a glutamate (K225E) was shown to 
have the same conformation as the wild-type by analytical ultra-centrifugation (Lee et 
al. 2008). This tryptophan and lysine (or arginine) interaction may not be important in 
maintaining the interface alone, however it may contribute to the overall stabilisation of 
the closed conformation. 
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1.3.3 The actin binding sites of α-actinin 
Various co-sedimentation assays with actin filaments have been used with different 
deletion constructs of the ABD (CH1-CH2) from various proteins to assess what 
regions are important for binding actin.  The ABD from smooth muscle chicken α-
actinin has been found to interact with filamentous actin (Kd = 4.7 µM) but not 
monomeric actin (Way et al. 1992). The same study also found the CH2 domain alone 
does not bind actin, whilst the CH1 domain does. However there was a ten-fold 
increase in affinity between the CH1 alone and the CH1-CH2 pair suggesting the CH2 
does play a role in the ABD:actin interaction. Further studies identified a major actin 
binding site (residues 120-134) (Kuhlman et al. 1992, Hemmings et al. 1992), 
referred to in other literature as actin binding site 2 (ABS 2). The equivalent region in 
human muscle α-actinin 2 (residues 126-140) is fully conserved and located on the last 
α-helix (helix G) of the CH1 domain (Figure 1.5A). For other spectrin family proteins 
with two CH domains (filamin and ABP-120), actin binding regions have been identified 
at a similar position (Bresnick et al. 1990, Bresnick et al. 1991, Lebart et al. 1994).  
Two actin binding sites have also been identified on the ABD of human dystrophin by 
proton NMR (Levine et al. 1992); ABS1 (residues 17-26) and ABS 3 (residues 128-
156) (Figure 1.5B). ABS 1 has been found to be the most prominent actin binding site 
by co-sedimentation of deletion constructs (Fabbrizio et al. 1993). It has commonly 
been suggested that the equivalent regions in α-actinins (residues 40-49 and residues 
141-173) (Figure 1.5B) are involved in actin binding as dystrophin and α-actinin are 
both part of the spectrin superfamily and they both have two CH domains. However, 
from the studies mentioned above, it is unclear if the CH domains of dystrophin and α-
actinin interact with actin filaments in the same way. α-actinin constructs only 
containing either ABS 1 and ABS 3 only show weak affinity to actin (Kuhlman et al. 
1992), which is the opposite to that found for dystrophin. Also, a KTFT motif is present 
in spectrin family members within ABS 1, is not critical for binding actin (Corrado et al. 
1994). In addition, ABS 2 has not been identified as an actin binding site for dystrophin 
despite a number of conserved resides being present in both α-actinin and dystrophin 
(Figure 1.5B). The residues present in the ABS 2 of α-actinin that are not present in 
the ABS of dystrophin (Figure 1.5B, red) may be important for the α-actinin:actin 
interaction. 
On the other hand, the full length α-actinin ABD has a higher affinity for actin than 
partial constructs which contain ABS 2 (Kuhlman et al. 1992), suggesting the 
presence of other weaker actin binding sites. In addition, the affinities of the α-actinin 2 
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and dystrophin CH domains for actin are comparable (7.5 µM and 5.9 µM) (Haywood 
et al. 2016 and Fabbrizio et al. 1993). Interactions of the ABD of α-actinin and actin 
may involve the conserved residues situated in ABS 1 and 2.   
The studies outlined above were performed before the crystallographic structures of 
the ABD from the α-actinin isoforms were solved. There is a clear actin binding region 
within ABS 2 (in CH1) and ABS 3 (in CH2) that is exposed to solution. It has been 
proposed that the ABD initially interacts with actin in a closed conformation using this 
actin binding region (Borrego-Diaz et al. 2006). The ABD crystal structures also show 
the ABS 1 partially buried within the CH1-CH2 interface and a number of residues 
within the ABS 1 form contacts with the CH2 domain (Figure 1.5A). Either a 
conformational change is required to allow the ABS 1 to interact with actin (Franzot et 
al. 2005) or the ABS 1 is not directly involved in interacting with actin and is instead 
involved in maintaining the overall actin binding domain fold required for initial binding 
to the actin filament.  
1.3.4 Models for the ABD (CH1-CH2) bound to actin filaments 
Generating high resolution models of α-actinin bound to actin filaments has been a 
challenge as the crystallographic structure of filamentous actin has yet to be solved. 
Therefore, there are no crystallographic structures of the ABD bound to filamentous 
actin. However, models of the ABD from α-actinin bound to actin filaments have been 
generated by cryo-EM. In a 3D reconstruction of chicken gizzard α-actinin homodimers 
cross linking F-actin, the densities attributed to the N-terminal ABD at one end were fit 
by a closed conformation but the at the other end of the dimer, the densities were 
consistent with an open conformation of the ABD (Liu et al. 2004, PBD code 1SJJ). 
However, the resolution for this model was quite low (20 Å), therefore fitting 
conformational models to the densities becomes problematic. Another study generated 
a low-resolution density map of 16 Å of an actin filament (consisting of 10 G-actin 
subunits) by Cryo-EM, with the CH domains bound to every cleft between actin 
subunits (Galkin et al. 2010, PDB code 3LUE). In this case, the densities bound to the 
actin filament were only large enough for one CH domain.  The CH1 domain from the 
crystal structure of the α-actinin 3 ABD (PDB code 1WKU) was fitted to these densities 
and it was hypothesised that the CH2 domains were unbound and free in solution. 
However, in generating this data, the actin filaments were saturated with CH domains 
(one per G-actin subunit). This saturation does not occur in the Z-discs and could be 
the cause of the unbound CH2 domains, which do not bind due to steric clashes. Fitting 
the CH1 domain and the CH2 domain in a closed conformation into the extra density 
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did show steric clashes between the CH2 domain and the actin filaments. This 
suggests in the final bound state the orientation of the CH1 domain is such that it is 
unlikely for the CH1-CH2 to be in a closed conformation. In the same study it was also 
suggested that the role of the CH2 domain is to inhibit CH1, however full length α-
actinin ABD (CH1 and CH2) has a higher affinity for actin than the CH1 domain alone 
(Way et al. 1992).   
EM studies have also been conducted with other members of the spectrin family that 
have N-terminal CH domain pairs. For the dystrophin ABD1, a large bilobed shaped 
density bound to the actin has been observed by cryo-EM (Sutherland-Smith et al. 
2003) using a 1:2 ratio of actin to ABD1. This was attributed to an ABD1 dimer bound 
to the actin filament. A more recent study has reported a 1:1 (ABD1 : actin) 
stoichiometry, and that the two CH domains remain in a closed conformation when 
bound to F-actin (Singh and Mallela 2012). There has been much controversy over 
how the ABD of utrophin interacts with filamentous actin. Cryo-EM reconstructions of 
the ABD with actin over the years have suggested different conformational models.  An 
early reconstruction suggested that utrophin binds to actin via an induced fit 
mechanism (Moores et al. 2000). Later reconstructions have indicated both an 
extended conformation (Galkin et al. 2002) and a closed compact conformation 
(Sutherland-Smith et al. 2003). Recent biochemical analysis of utrophin ABD 
mutants, thought to be permanently in a closed conformation, showed that there was a 
dramatic decrease in the binding affinity for actin in the mutant compared to the wild 
type (Broderick et al. 2012), supporting the open conformation model.  Overall there 
has been little uniformity between how pairs of CH domains from the spectrin family 
interact with actin filaments reported by EM studies. This could be because of two 
reasons; (1) There is no universal way CH1-CH2 domains from different proteins 
interact with actin filaments and/or (2) the density maps from the EM studies to date 
have been of a low resolution, therefore the CH1-CH2 conformations fitted to the 
models are not the conformations in vivo. With the development of direct detectors for 
EM it is now possible to generate higher resolution models, which may better answer 
how the CH domains of α-actinin and other members of the spectrin family bind actin 
filaments. 
Most recently a high-resolution model for the actin binding domain (two CH domains) 
from human filamin A bound to phalloidin stabilised actin has been generated 
(Iwamoto et al. 2018). In this model a resolution of 3.6 Å has been reported for the 
actin filament and the CH1 domain. Also, in model the CH2 domain has been resolved 
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to a lower resolution. The two CH domains can be seen in an open conformation with 
the CH2 domain unbound to the actin and the lower resolution of the CH2 domain 
suggests it is mobile. The CH1 domain of filamin A is seen to be inserted in the cleft 
between actin subunits and three actin binding sites were identified: (1) A short 
sequence located at the N-terminal end of helix A termed the ABS-N, (2) a short 
sequence located from the middle of C-E loop to the N-terminal end of  termed ABS 2’ 
and (3) a major actin binding site starting from the E-F loop and ending in the middle of 
helix G termed ABS 2. The previously reported ABS 1 and ABS 3 were found not to 
interact with actin in this model. Comparison of the protein sequence of human filamin 
A and α-actinin 2 (Figure 1.5C) shows residues at these regions are conserved 
between the proteins, suggesting the CH 1 domain of α-actinin 2 also interact with 
filamentous actin in a similar manner. The important actin binding residues identified in 
the ABS-N of filamin A (L35 and W41) are also present in α-actinin 2 (L30 and W36). 
The ABS 2’ sequence is not highly conserved between α-actinin 2 and filamin A apart 
from two arginines (R89 an R93 in α-actinin 2). The major actin binding site ABS 2 is 
highly conserved.  One major difference is four residues in helix F. This is interesting 
as in the EM model of filamin A the helix F is buried in the cleft between the two actin 
subunits with resides D125 and K127, which α-actinin 2 does not have, forming 
important contacts with both actin subunits. Within this four-residue region α-actinin 2 
has two negatively charged glutamates that filamin A does not have, E120 and E121, 
which may be involved in interacting with the actin subunits. It is also interesting to note 
W142 (W135 for α-actinin) on the helix G thought to stabilise the CH1:CH2 interface by 
interacting with a charge residue (Figure 1.4F) also forms hydrophobic contacts with 
actin in the bound state.  
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Molecular dynamic simulations were used to study the chicken smooth muscle α-
actinin CH1-CH2 conformation when bound to the actin filament (using the structure 
generated by Liu et al. 2004) (Shams et al. 2016). An overall actin binding mechanism 
was proposed whereby: (1) in a closed conformation the CH2 domain binds to the actin 
filament first, (2) the binding to actin induces a conformational change in the ABD from 
the closed to open conformation, (3) the CH2 domain disassociates from the actin and 
(4) the CH1 domain migrates to the cleft between two G-actin subunits. It has been 
hypothesised the CH domains initially bind in a closed conformation as the ABS 1 (on 
CH1) and ABS 2 (on CH2) (Figure 1.5A) together make an actin binding region 
(Borrego-Diaz et al. 2006). However, there is no experimental evidence to support the 
idea that the CH2 domain binds actin first.  The dissociation of the CH2 domain from 
actin in the final bound state is supported by EM models (Galkin et al. 2010, Iwamoto 
et al. 2018). Overall, there is limited experimental evidence of the mechanism for the 
CH domain binding actin to support the model proposed by Shams et al. 
This same study also suggested how CH1 binds the cleft between proximal actin 
monomers. The CH1 residues K32, R35 and E115 (Figure 1.5D, α-actinin 2 equivalent 
(residues K38, R41 and E121 dark blue)) interact with the actin residues D363, E125 
and K118 from one actin monomer. The CH1 residues K80, R83 and E114 (Figure 
1.5D, α-actinin 2 equivalent (residues K86, R89 and E120 cyan)) interact with the actin 
residues E364 and R372 from the actin monomer on the other side of the binding cleft.  
The actin binding residues proposed by molecular dynamic simulation (Shams et al. 
2016) are within or near the actin binding sites proposed for filamin A (ABS-N, ABS 2’ 
and ABS 2) (Iwamoto et al. 2018, Figure 1.5C), thus suggesting α-actinin binds actin 
in a similar manner. The residues K86 and R89 (Figure 1.5D) are located in the ABS 2’ 
and the filamin equivalent of K86 (R91) has been proposed to be important for actin 
binding (Iwamoto et al. 2018). The residues E120 and E121 are located in the helix F 
situated in the ABS 2 region and are highly likely to directly interact with actin. The α-
actinin 2 residues K38 are R41 are located very near to the filamin A ABS -N. A mutant 
of α-actinin 1 linked to congenital macrothrombocytopenia (CMTP) R46Q, the 
equivalent to R41 of α-actinin 2, is reported to have an increased affinity to actin 
(Murphy et al. 2016). If R41 does form a salt bridge with actin, as suggested by 
Shams et al., then the mutation to glutamine should decrease the ABD affinity to actin. 
However, R41/R46 forms a possible salt bridge at the CH1-CH2 interface (Borrego-
Diaz et al. 2006) (Figure 1.4D) and the increased affinity can be attributed to the 
lowering of energy required for transition between the closed and open conformations. 
Therefore, characterisation of the binding affinity of this mutant alone cannot determine 
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if R46 directly interacts with actin or not. For the other charged residues not at the 
CH1-CH2 interface, actin affinity experiments could be used determine if they are 
important in binding actin.  
1.3.5 Regulation of α-actinin in the Z-disc 
Models from EM density maps of the Z-disc lattice have shown a regular arrangement 
of the α-actinin homodimers. In vitro, the CH domain from α-actinin can fully decorate 
the actin filament, which does not occur within the Z-disc (Galkin et al. 2010).  It has 
been suggested that the Z-repeat (Zr) domains of titin act as a scaffold for the α-actinin 
molecules in the Z-discs (Sorimachi et al. 1997, Gautel 1996). The calcium insensitive 
C-terminal EF 3-4 hand of α-actinin 2 (Nakayama et al. 1994) has a strong affinity to 
the Zr 7 domain (Kd ~120 - 190 nM) (Young and Gautel 2000, Joseph et al. 2001). 
However, the EF 3-4 hand of α-actinin 2 does not interact with all the Z-repeats with the 
equal affinity.  Z- repeats 1, 3 and 7 bind the EF 3-4 domain with high affinity, whilst Z- 
repeats 2, 4, 5 and 6 bind weakly (Joseph et al. 2001). Surface plasmon resonance 
studies show that the Zq domain of smooth muscle titin has a high affinity to the SR2-
SR3 domains of smooth muscle α-actinin (Kd ~ 344 nM) and it was proposed in the 
same study to interact with the same α-actinin bound to the Zr7 domain between the 
SR2 and SR3 domains (Chi et al. 2008). 
The structure of EF 3-4 from α-actinin 2 in complex with the Z-repeat of titin (Zr 7) was 
solved by NMR (Atkinson et al. 2001, PDB code 1H8B). The more recent crystal 
structure of the α-actinin 2 homodimer (Ribeiro et al. 2014) showed that the EF 3-4 of 
one monomer interacts with the ABD- spectrin repeat 1 alpha helical linker region of 
the opposing monomer further. This interaction is very similar to the Zr7- EF 3-4 
complex (Atkinson et al. 2001) whereby the α-helix linker region inserts into the EF 
hand and interacts mainly via a 1-4-5-8 hydrophobic binding motif (Ribeiro et al. 
2014). It has been suggested the α-actinin 2 homodimer auto-inhibits the interaction 
between the EF 3-4 domain and Z-repeats repeat domains of titin. The capacity for the 
EF 3-4 hand to bind the Z-repeats of titin is thought to be regulated by the the 
phosphoinositide, PtdIns(4,5)P2 (PIP2), which is present within the Z-disc (Fukami et 
al. 1992) and can bind to the CH2 domain (residues 168 – 184) of α-actinin in chicken 
striated muscle (Fukami et al. 1996). It has been suggested that the binding site for 
the negatively charged head of PIP2 in α-actinin 2 and 3 is a triplet of arginine residues 
on the CH2 domain (Figure 1.5E) (Franzot et al. 2005, Ribeiro et al. 2014). The 
mechanism by which PIP2 regulates the binding of α-actinins to titin in the Z-discs is 
still unclear. A model has been proposed whereby upon PIP2 binding to the CH2 
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domain, the fatty acid chain of PIP2 disrupts the interaction between the EF 3-4 domain 
and the linker region, freeing EF 3-4 to bind the Z-repeats (Ribeiro et al. 2014). 
However, this model has yet to be proven experimentally. It is also thought that the 
binding affinity of α-actinin to actin increases in the presence of PIP2, however the 
increase in binding affinity has yet to be quantified. The addition of PIP2 to a solution 
containing actin filaments and α-actinin 2 has shown an increased gelation suggesting 
PIP2 increases the affinity of muscle α-actinin to actin (Fukami et al. 1992), however 
this has not been investigated further. 
1.4 Mutations in α-actinin linked to disease 
1.4.1 Identification of disease-causing mutations 
Mutations in the α-actinin genes (isoforms 1, 2 and 4) have been identified in 
individuals with a number of different genetic diseases by genome sequence analysis. 
These mutations maybe the cause or a contribution to the manifestation of the 
diseases by changing the properties of the α-actinins. Twenty mutations within the non-
muscle α-actinin 1 gene sequence have currently been identified in individuals with a 
group of disorders called congenital macrothrombocytopenia (CMTP) (Nakayama et 
al. 2013, Gueguen et al. 2013, Yasutomi et al. 2016, Westbury et al. 2015, 
Kunishima et al. 2013, Bottega et al. 2015). CMTP is characterised by both 
abnormally large platelets and a reduced platelet count (Kunishima and Siato 2006). 
Twelve mutations in the non-muscle α-actinin 4 gene have also been found in 
individuals with focal segmental glomerulosclerosis (FSGS), a kidney disease (Choi et 
al. 2008, Safarikova et al. 2013, Barua et al. 2013, Weins et al. 2005, Feng et al. 
2016, Buscher et al. 2018). The disease is defined as sclerosis in the glomerulus 
region of the kidney (Jefferson and Shankland 2014). The mutations associated with 
CMTP and FSGS are located throughout the amino acid sequence of α-actinin 1 and 4 
respectively. However, most of the mutations are situated in the N-terminal actin 
binding domain and the C-terminal EF 1-2 hands. There are no mutations within 
muscle α-actinin 3 associated to any types of myopathy, however there is a premature 
stop codon producing a R577X α-actinin 3 variant (North et al. 1999). 
For muscle α-actinin 2, nine point mutations have been identified in individuals with 
cardiomyopathy (Theis et al. 2006 ref, Chiu et al. 2010 refed, Girolami et al.  2011). 
Cardiomyopathy is a characterised by irregularity in the heart muscle. There are two 
types of this disease; hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy 
(DCM). HCM is characterised by ventricle wall thickening of the left ventricle wall, and 
DCM is characterised by a thinning of the ventricle wall.  The point mutations are 
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located throughout the α-actinin 2 sequence.  Four mutations are present in the N-
terminal ABD; Q9R, G111V, A119T and M228T and therefore may alter the ABD:actin 
interaction. Three mutations, T495M, E583A and E628G, are present in the rod 
domain. The two negatively charged glutamates, which are mutated to small 
hydrophobic residues, may play a part in disrupting the binding of other Z-disc proteins. 
Two mutations linked to HCM (R795T) and DCM (H775Y) are located near each other 
on EF1-2 of the C-terminal CAM-like domain. It is unclear at this point why one 
mutation causes HCM whilst the other causes DCM. The mechanisms causing both 
HCM and DCM are currently not known, and it is unclear why some mutations cause 
the HCM phenotype and others the DCM phenotype.  
1.4.2 Mutation in the actin binding domain causing disease 
α-actinins have a major role as actin filament crosslinking proteins integral to actin 
cytoskeletal networks, such as the Z-disc lattice. Many of the mutations linked to HCM, 
FSGS and CTMP are regularly found in the actin binding domain (across isoforms 1, 2 
and 4) (Figure 1.6A). Therefore, many studies have focused on how α-actinin function 
is altered by the ABD mutations.  For CTMP α-actinin 1 mutants, HeLa cells were 
transfected with the mutant (Q32K, R46Q, V105I and E225K) to determine how the 
actin filament network and α-actinin localisation compared to non-transfected cells by 
immuno-fluorescence microscopy (Murphy et al. 2016). No distinguishable differences 
between α-actinin 1 mutant transfected cells and transfected cells were observed. 
Western blot analysis did however show that there were more mutant α-actinins 
present in the cytoplasm compared to wild type. Either there are only subtle changes in 
the actin cytoskeleton and α-actinin 1 localisation or there are other factors in play, for 
example the stability of α-actinin 1 or the disruption of a different binding partner. For 
FSGS α-actinin 4 ABD mutants, the mis-localisation of α-actinin 4 with the individual 
mutations W59R, I149del, K255E, T259I and S262P has been reported in podocytes 
(usually to a small region just outside the nuclei) (Weins et al. 2005). Also, the α-
actinin 4 K255E mutant has been shown to cause an increase actin aggregation in lung 
fibroblasts (expressing the mutant) and forms disordered network actin filaments 
networks in vitro (Weins et al. 2007). The point mutations in muscle α-actinin 2, G111V 
and A119T, associated with HCM have been shown to cause delocalisation of α-
actinins to the outside of the Z-disc regions and increased α-actinin aggregation in 
cardiomyocytes.  
In vitro studies of different α-actinin ABD mutant constructs, from α-actinin 1, 2 and 4, 
with filamentous actin have shown that there the mutations tend to increase the affinity 
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of the ABD for filamentous actin. With this in mind the mutations currently identified 
have been mapped out here on the ABD of α-actinin 2 (PDB code 5A36) (Figure 
1.6B), to evaluate common positions of the mutated residues and indicate important 
actin binding regions. It is clear the majority of mutated residues are located at the 
interface between the CH1 and CH2 domains (Figure 1.6C).  There is a run of four 
mutated residues, associated to FSGS (α-actinin 4), along the length of the G-helix of 
the CH2 domain, (K225E, T259I, S262P/F and Y265H). Different ABD constructs with 
separate mutations (K225E, T259I, S262P) have been found to have a higher affinity to 
actin compared to the wild-type (Kd = 25 – 35 µM, Kd of the WT not determined) (Lee 
et al. 2008). The exact affinity of these mutants to actin is uncertain as another study 
reported a ~ 6 fold increase in binding affinity to F-actin from an ABD K255E construct 
(residues 1-271) (Kd ~ 5 µM) compared to wild-type (Kd ~ 32 µM) (Weins et al. 2007). 
However, both studies demonstrated that the binding affinity of ABD K255E for F-actin 
was greater than the wild-type. Increased bundling of actin by full length α-actinin 4 
with the Y265H mutation in vitro, has also been reported (Feng et al. 2016). The K255 
residue is thought to be part of an important interaction with W147 at the CH1-CH2 
interface (Borrego-Diaz et al. 2006). The crystal structure of the ABD of α-actinin 4 
K255E shows it to be in a closed conformation and analytical ultra-centrifugation 
suggests the ABD constructs with the mutations K225E, T259I, S262P are in closed 
conformations when free in solution (Lee et al. 2008). Although the mutations do not 
change the ABD conformation, it is hypothesised they weaken the interaction between 
CH1 and CH2 so that the energy required for the transition from closed to open 
conformations is lowered, thus, increasing the affinity to actin (Lee et al. 2008). 
This mechanism is supported by molecular dynamic simulations of the ABD from 
chicken smooth muscle α-actinin (Shams et al. 2016). The simulations of the K255E 
equivalent mutation in chicken smooth muscle α-actinin (K237E) indicated that this 
mutation reduces the force required to separate the CH domains. Also, the average 
interaction energy with F-actin was less for the mutant compared to the wild-type. This 
indicates that the increase in binding affinity observed is not through direct interactions 
with the actin filament (Weins et al. 2007, Lee et al. 2008). It is also interesting to note 
that the α-actinin 4 ABD K255E mutation together with two other mutations Q52A and 
T55A, had a reduced affinity to actin (Kd ~ 33 µM) compared to the ABD construct with 
K255E mutation alone (Kd ~ 5 µM) (Weins et al. 2007). The residues Q52 and T55 
(helix G, CH1) are also involved in interactions at the CH-CH2 interface, therefore the 
mutations should further reduce the energy required for the transition from the closed 
state to the open state. However, a reduction in binding affinity to F-actin was 
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observed. One possible explanation for this is the residues Q52 and T55 lie in one of 
the actin binding sites (ABS 1) and so are directly involved in binding F-actin. Another 
is that the conformation of the ABD with the triple mutation favours an open 
conformation not a closed conformation. It has been proposed that the CH2 domain 
initially binds the actin filament with the ABD in a closed conformation (Shams et al. 
2016, Borrego-Diaz et al. 2006), therefore the mutations may disrupt the ABD 
conformation required for preferential initial binding. However, there is no evidence that 
the ABD mutant construct (K255E, Q52A and T55A) is in an open conformation and 
the affinity of the mutant construct observed was very similar to the wild-type. 
Along helix A of CH1 there are three mutated residues linked CMTP; Q32K, F37C, 
R46Q/W and one linked to FSGS; W59R. (Figure 1.6C) The ABD of α-actinin 4 with 
the W59R mutation has been shown have an increased affinity to F-actin, similar to the 
K255E mutant (Weins et al. 2005). The mutant R46Q had a marked increase in affinity 
(Kd = ~0.7 µM) compared to the wild-type (Murphy et al. 2016). The crystallographic 
structures of α-actinin ABDs show the Q32 and R46 sidechains form contacts with the 
CH2 domain, therefore the mutations would disrupt these interactions. It should be 
noted that the uncharacterised mutation F37C is present in the proposed actin binding 
site 1, however it is part of the KTFT motif which has been shown to be not important in 
F-actin binding (Corrado et al. 1994). It can be hypothesised that the mutations on the 
α-helices A (CH1) and G (CH2) weaken the CH1-CH2 interface, thereby increasing 
affinity to F-actin. The HCM linked mutated residue M228 is also situated at this 
interface suggesting that the M228T mutation may also have an increased binding 
affinity to F-actin. 
There are mutations linked to disease which are not located at the interface and 
therefore highlights regions on the ABD which may directly bind actin. The α-actinin 4 
mutations I149del and F153L are both within actin binding site 2 (helix G, Figure 1.6C) 
and the I149del ABD construct has an increased affinity for F-actin (Weins et al. 2005). 
Why the deletion of this hydrophobic residue increases actin affinity is unclear. For α-
actinin 1 CMPT linked mutations, there are two mutations found on the F helix of CH2; 
E225K and V228I which may be involved in binding actin. The mutation E225K on α-
actinin 1 also has an increased affinity to actin (Murphy et al. 2016). 
The α-actinin 2 HCM mutation A119T is located on the F helix of CH1 (Figure 1.6D) 
and it has been hypothesised this helix is buried in the cleft between adjacent G-actin 
subunits with E120 and E121 both forming salt bridges with the different actin subunits 
(Shams et al. 2016). The G111V mutation is located on the loop between helices E 
 
 
29 
 
and F (Figure 1.6D). The α-actinin 1 CMPT mutation V105I has been shown to 
increase binding affinity to actin (Murphy et al. 2016). The α-actinin 2 V105 equivalent 
residue (V112) is next to G111, this suggests this region is important for actin binding. 
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 Chapter 2 - General methods and materials 
2.1 Chemicals 
All chemicals and materials used during this project were supplied by Sigma, unless 
otherwise stated. 
2.2 Sterilising Media 
For expression of proteins, all lysogeny broth (LB) and LB AGAR was autoclaved 
before use. All buffers used in protein purification were filtered sterilized using a 45 μm 
filter (Milipore).  
2.3 Escherichia coli strains 
For plasmid generation NEB 5α cells were used and are deficient in endA proteases 
and resistant to phage T1. For expression of proteins BL21(DE3) cells were used 
(NEB). BL21(DE3) is a standard T7 expression strain that is deficient in Lon and OmpT 
proteases and resistant to phage T1.  
2.4 Transformations 
All E. coli strains used were chemically competent and therefore the introduction of 
vectors into E. coli cells was done via heat shock transformations. The transformation 
protocol used was as follows. In a 1.5 mL eppendorff, 1 μL of plasmid was added to 10 
– 20 μL of E.coli stock from NEB and left on ice for 20 mins. The plasmid and cell 
mixture was then incubated at 42 ºC for 30 secs. The mixture was left on ice for a 
further 30 mins for recovery of the cells. 200 μL of SOC media was added to the cells 
and both were incubated at 37 ºC for 1 hr at 200 rpm, for cell culture growth. The 
transformed cells were spread onto petri dishes with LB-agar with the appropriate 
antibiotic (kanamycin 34 μg mL-1 or ampicillin 100 μg mL-1). The plates were incubated 
overnight at 37 °C. 
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2.5  Molecular Biology  
2.5.1 Plasmids 
All plasmids used during this project can be found in Table 1 and the vector maps can 
be seen in Figure 2.1. 
2.5.2 Single Stranded DNA Primers 
DNA primers (Table 2) for PCR and sequencing were designed using Primer3Plus 
web-based tool and primers for site directed mutagenesis were designed by PimerX 
web-based tool. All primers were ordered from Integrated DNA Technologies (IDT). All 
primers were made up to a 100 μM stock in dH20 and stored at -20 ºC. 
2.5.3 Polymerase chain reaction (PCR) 
A Bio-Rad T100™ Thermal Cycler was used for the PCRs. A typical PCR had the 
following mixture, made up in a PCR tube: 10 μL 5x Phusion High Fidelity (HF) buffer, 
1 μL dNTP (a mixture of deoxynucleotides is required in the polymerase reaction) (10 
mM stock), 1 μL forward primer (10 μM stock), 1 μL reverse primer (10 μM), 1 μL 
template vector, 1 μL Phusion® HF DNA Polymerase (NEB, 2 units μL-1), 1.5 μL 
DMSO (optional) and dH20 to make the final volume 50 μL. After the PCR the products 
were ran on an agarose gel to verify the PCR had worked followed by gel extraction. 
2.5.4 DNA Gel extraction and Plasmid purification (mini-preps) 
A Qiagen gel extraction kit (28704) was used for the extraction of DNA after agarose 
gel electrophoresis. The manufacture’s protocol was followed. First the DNA bands 
were excised from the gel. Then a 4x volume of agarose solubilisation buffer was 
added to the excised gel and heated to 50 ºC for 10 mins. The DNA in the media was 
applied to a silica membrane column and briefly centrifuged (17,000 xg) so the media 
passed through the membrane. After which the membrane was washed with 700 µL 
high salt buffer followed by 750 µL high ethanol media to remove the salt from the 
membrane. The DNA was eluted off the membrane in 50 µL of dH2O. 
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Qiagen miniprep kits (27104) were used for the purification of plasmids. Qiagen 
miniprep kits use alkaline/SDS conditions for cell lysis and silica membranes to isolate 
the plasmid DNA in high salt conditions.  5 mL cultures of NEB 5α cells were grown 
overnight at 37 ºC, 200 rpm. The cells were then pelleted by centrifugation (3000 xg, 
20 mins, at 4 ºC). The LB was removed and resuspended in 250 µL resuspension 
buffer with RNase A. 250 µL of lysis buffer was then added, mixed and incubated at 
room temperature for 5 mins. After incubation of the lysis buffer 350 µL of 
neutralisation/ high salt buffer was added and mixed thoroughly. The lysate was 
centrifuged at room temperature (17,000 xg) for 10 mins and the lysate was removed 
from the precipitate. The lysate was applied to a column with a silica membrane and 
the column was centrifuged for 1 min at 17,000 xg. The membrane was then washed 
with 900 µL of a high salt buffer followed by a high ethanol wash to remove the salt. 
The column was further centrifuged for 5 mins at 17,000 xg to remove any excess 
ethanol on the silica membrane. The DNA was eluted off the column in 50 µL dH2O.  
2.5.5 Digestion of DNA by Endonuclease restriction enzymes 
High-Fidelity (HF®) restriction enzymes (NEB) were used to cut vectors and DNA inserts 
at specific restriction sites. In a double endonuclease restriction digest, 1 μg of DNA 
vector was digested using 0.5 μL of each restriction enzyme in CutSmart buffer (NEB) 
(2 μL of 10x stock) in a volume of 20 μL made up with dH2O, at a temperature of 37 ºC 
for 1-2 hour.  
2.5.6 Agarose Gel electrophoresis 
Agarose gel electrophoresis is used to separate DNA fragments of different sizes within 
a sample. 10 µL of 6x purple loading dye (NEB) was added to 50 µL DNA samples 
before electrophoresis to access the DNA movement through the gel during 
electrophoresis. A 30 μL DNA sample was loaded into an individual well of a 1 % 
agarose gel (1 g agarose in 100 mL TAE buffer with 1 μL Invitrogen™ SYBR™ Safe 
DNA Gel Stain (10,000x stock)). SYBR™ Safe was used to visualize the DNA bands in 
the gel. The gels were immersed in TAE buffer (1x) in a Mini-Sub® cell GT (BioRad) 
and the gel was ran at 100 V for typically 40 mins. The gels were imaged in a 
ChemiDoc XRS+ (BioRad). If DNA bands in the gel needed to be purified they were cut 
out using a sterile scalpel and then a gel extraction kit (Qiagen) was used to purify the 
DNA (manufacture protocol was followed). 
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2.5.7 Ligations 
In this work ligations were used to insert Affimer DNA sequences into empty pET11a 
vectors. In a ligation reaction the following was added: 75 ng linear pET11a, 25 ng of 
Affimer DNA insert, 2 μL 10x T4 ligase reaction buffer, 1 μL T4 ligase (NEB, 400 units 
μL-1) and dH2O to make up to a final volume of 20 μL. The ligation mixture was 
incubated at room temperature for 1 hr. 1 μL of the ligation mixture was then used for 
transformation into NEB 5α cells. The subsequent colonies growing on the LB-agar 
plates the next day were picked to grow in 5 mL starter cultures. The starter cultures 
were used for minipreps and the resulting purified plasmids were sent for sequencing 
the verifying the ligations were successful. 
2.5.8 Measuring dsDNA concentrations 
The absorbance at 260 nm of dsDNA can be measured using a spectrophotometer. 
dH2O was used as a blank. A Nano Photometer® NP80 (IMPLEN) as used with 1-2 μL 
of the dsDNA sample. Measuring the A260 can be used to calculate the dsDNA 
concentration:  
When A260 =1.0, there is 50 µg mL-1 of dsDNA present in the sample.  
2.5.9 Sequencing 
Sequencing data was used to verify that the correct DNA sequence is in the vector with 
no mutations and was in frame. Purified plasmid samples were sent to GATC Biotech. 
Typically, uninterrupted 600 bp reads were common for one sequencing dataset. 
Therefore, longer constructs needed more than one reaction. Sequencing primers for 
the full length α-actinin 2 gene were designed using Primer3Plus. For sequencing of 
Affimer constructs in pET11a the T7 forward primer was used. 
2.6 Protein expression 
All protein constructs (Table 3) were expressed in BL21(DE3) cells (NEB). The cells 
were typically grown in a 2 L incubation flask using 400 mL of lysogeny broth (LB) with 
either kanamycin 34 μg mL-1 or ampicillin 100 μg mL-1 depending on the plasmid 
present in the E.coli culture grown (Table 1). 200 mL of LB was used for Affimer 
expression. The freshly autoclaved LB with antibiotic was inoculated with a 10 mL 
starter culture of the cells. Stater cultures were prepared by picking a fresh colony and 
using the colony to inoculate 10 mL of fresh LB (with the appropriate antibiotic) then 
incubating the culture overnight (37 ºC, 220 rpm).  The 400 mL cultures were incubated 
at 37 °C, 220 rpm for typically 2-3 hours until the OD600 reached 0.6 (measured using a 
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CARY 50 BIO (Varian) spectrophotometer). Protein expression was induced using 
IPTG. The concentration of IPTG used and the incubation temperature / time used 
depended on the protein expressed (Table 4). 
2.7 Lysis of BL21(DE3) cells 
After expression the cells were pelleted by centrifugation (3,000 xg, 4 °C, 30 mins) in a 
Thermo scientific Hercaeus Megefuge 16R. The cells were then re-suspended in the 
appropriate lysis buffer. Cells were lysed by sonication, 10 secs on and off, six times at 
40% amplitude using a Vibra-cell™ (Sonics) sonicator. Before purification of the 
proteins the lysates were centrifuged to remove cell debris. Lysates were centrifuged 
(30,000 xg, 4 ºC, 45mins) using a Beckman Avanti J series centrifuge with a JA 25.50 
rotor.  
2.8 Determining protein sample concentrations and quality 
2.8.1 Measuring protein concentration 
Protein sample concentrations were calculated using the Beer-Lambert law: 
Awavelength = Concentration (M) x path length (cm) x extinction coefficient (M-1 cm-1) 
The absorbance at 280 nm of a protein was measured using a spectrophotometer. The 
buffer the protein sample is in is used as a blank for the spectrophotometery. For small 
volume protein samples (1-2 μL), a Nano Photometer® NP80 (IMPLEN) as used. With 
larger protein samples (at least 500 μL) a CARY 50 BIO (Varian) was used. The 
extinction coefficient can be calculated using the protein sequence:  
Extinction Coefficient of a protein (at A280) = (5500 x n(Trp)) + (1490 x n(Tyr)) + (125 
n(Cys)) 
2.8.2 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS 
PAGE) 
An SDS PAGE was used to assess the MW of a given protein and to assess the purity 
of a sample. Unless otherwise stated all equipment used for a SDS PAGE was ordered 
from BioRad. 2x Laemmli sample buffer was added to a protein sample (1:1) ratio 
which was then heated to 100 °C for 5 mins. 1x Laemmli buffer contains 0.125 M Tris-
HCl pH 6.8, 30% sucrose, 0.04 % bromophenol blue, 2% SDS, 5 % β mercaptoethanol. 
Heating the sample results in fully denatured proteins with SDS bound, giving all the 
proteins a negative charge. Gels used during the project were either Mini-PROTEAN® 
TGX™ Precast 4-20 % acrylamide/Bis-acrylamide gels or lab made 1 mm 12 % 
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acrylamide/Bis-acrylamide gels using a Mini-PROTEAN® Tetra handcast systems. The 
gels were run in a Mini-PROTEAN® Tetra Cell System, immersed in 1x Glycine Tris 
SDS running buffer (Severn Biotech Ltd.) at constant voltage (200 V) for ~ 45 mins. 
The gels were stained with Quick Blue stain (TripleRed) for 1 hr at room temperature 
on a rocker and washed with dH2O. The stained gels were imaged using a BioRad 
ChemiDoc XRS+. 
2.8.3 Freezing protein samples for long term storage 
During the project protein samples were regularly frozen and either stored in an -80 °C 
freezer or in a liquid nitrogen dewar for long term storage. To minimize the damage of 
the protein samples during freezing, the samples were either frozen in liquid nitrogen or 
in an ethanol/dry ice bath. The samples were either pipetted drop-by-drop into liquid 
nitrogen or aliquoted into eppendorf tubes (30 μL maximum), and then frozen. Also, to 
minimize damage during thawing of the samples, they were thawed quickly in hand. 
2.9 Preparation of rat cardiomyocytes for staining 
Cardiomyocytes (CDM) were isolated by Dr. Ruth Hughes from heart muscle of adult 
male Wistar rats. The CDMs were collected in Tyrodes buffer, which was exchanged 
for cardiomyocyte media (M199 media, Gibco, supplemented with 5 mM creatine, 
5 mM taurine, 2 mM Na pyruvate, 2 mM L-carnitine, 0.1 μM insulin, 250 µg normocin, 
40 µM cytochalasin D) before the cells were seeded onto the coverslips. CDMs were 
incubated on either clean 13 mm glass coverslips or larger 25 mm coverslips (for 
dSTORM imaging) covered in laminin, for 2 hrs at 37˚C to allow for cell attachment. 
The CDMs were then fixed in 2 % PFA for 20 mins and stored at 4 °C until use. 
2.10 Microscopes 
For deconvolution microscopy, the cells were imaged using a DeltaVision Microscope 
(GE Healthcare Life Sciences) using the x100 oil objective. The dSTORM system used 
was built in-house by Dr. Alistair Curd and had the following specifications (as 
described in Tiede et al. 2016): an inverted microscope (Olympus, IX81) with a 60x, 
1.2 NA, water-immersion objective lens (Olympus, UPLSAPO60XW), and a cylindrical 
lens with f = 150 mm (Thorlabs, LJ1629RM-A) for generating astigmatism. Lasers at 
642 nm and 405 nm (Omicron, LuxX) provided widefield excitation and photo-activation 
of Alexa Fluor 647, together with a 2x beam expander before the rear illumination port 
of the microscope. Images were captured by a back-thinned, electron-multiplying CCD 
camera (EMCCD), cooled to - 80 °C (Andor Technology, iXON Ultra), using published 
scripts (York et al. 2011) called from the camera interface (Andor Technology, SOLIS). 
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2.11 Methods Tables 
Table 1- Plasmids  
 
Table 2 – DNA primers 
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Table 3 – Protein DNA sequences and their expression vectors  
 
 
 
Table 4 – Expression conditions for the different protein constructs. 
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 Chapter 3 - Generating and characterising Z-disc protein 
binding Affimers  
3.1 Introduction 
How Z-disc proteins localise within cardiomyocytes and other striated muscle cells has 
been incredibly difficult to study as the Z-disc regions are densely packed with different 
proteins and are very narrow, between 100 -140 nm in cardiomyocytes and slow 
striated muscle (Luther et al. 2003). Conventional fluorescence microscopy techniques 
give the spatial resolution of ~ 250 nm. Therefore, fluorescence microscopy can 
currently be used to identify proteins that localise to the Z-disc however, with the limited 
resolution, it cannot be used to study the organisation of proteins within Z-discs. With 
the development of super-resolution techniques, it is now possible to study Z-disc 
protein organisation using fluorescence microscopy. 
The super-resolution technique direct Stochastic Optical Reconstruction Microscopy 
(dSTORM) uses binders directly linked to commercial fluorescent dyes to label specific 
proteins within the cell for imaging (Heilemann et al. 2008, van de Linde et al. 2011). 
Antibodies have been widely used as binder for conventional fluorescent techniques. 
Following on from this, antibodies are widely used for dSTORM however, with the 
improved spatial resolution dSTORM offers (~ 20 nm in the x,y plane and ~ 50 nm in z 
(van de Linde et al. 2011)), antibodies are not the best binders for this technique. 
Antibodies are large (~ 10 nm in length) therefore there is a large distance between the 
fluorescent reporter dye and the target, a “linkage error” and they have trouble 
penetrating dense networks within the cell, such as the Z-discs. Also, producing 
antibodies is generally a lengthy and costly pursuit. More recently smaller antibodies 
variants such as the single chain camelid antibodies (nanobodies) have been used for 
fluorescence microscopy (Ries et al. 2012), which reduce this linkage error from ~10 
nm to ~2 nm.  However, like antibodies nanobodies can be time consuming and costly 
to generate. 
Twenty different small scaffold proteins unrelated to antibodies have been developed 
for research and medical applications with the aim of being cheaper and reliable 
alternatives to antibodies (Škrlec et al. 2015). Popular non-antibody binding proteins 
include DARPins, Monobodies, Affibodies, Anticalin, Affimer type I and Affimer type II. 
All of which are developed from proteins or protein domains chosen for their stability, 
small size and easy recombinant expression (Bedford et al. 2017). The scaffold 
structure of Affimers (type II) is the consensus sequence of plant phytosystatins, has 
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no cysteines in the sequence and is highly thermostable (Tm = 101 ºC) (Tiede et al. 
2014, Tiede et al. 2017). Each Affimer generated to bind a specific protein target has 
two unique binding loops (8 - 9 residues in length). Affimer sequences for binding 
specific proteins are quick and inexpensive to obtained by screening an Affimer phage 
library against a purified protein target by a phage display assay. Affimers are easily 
expressible in E. coli therefore they are also quick and inexpensive to make using 
common laboratory equipment and reagents. 
Affimers are highly suitable for use as binders for dSTORM. They are small (~ 12.5 
kDa) and therefore have a small linkage error (~ 2 - 3 nm). Also, a single cysteine can 
be inserted at the C-terminal end of the Affimer sequence to allow a single fluorescent 
dye molecule to be attached per Affimer molecule. Having the reporter dye molecule 
directly linked to the Affimer reduces the linkage error, compared to the introduction of 
a secondary Affimer binder with the reporter dye attached for example, using 
biotinylated Affimers followed by streptavidin conjugated to the reporter dye. Also 
having one dye molecule conjugated to one Affimer allows for more precise localisation 
of the Affimers in dSTORM.  These small binders have already been shown to work 
well as binders for fluorescence microscopy techniques. Actin binding Affimers directly 
linked to commercial dyes have been shown to label actin filaments in Hela cells as 
well as phalloidin and actin antibodies (Lopata et al. 2018). Also, actin binding Affimers 
conjugated to a docking DNA strand have been used to image actin filaments in Cos7 
cells by DNA-PAINT imaging (Schlichthaerle et al. 2018). Tubulin binding Affimers 
have also been used image microtubules by dSTORM (Tiede et al. 2017).  
The aim of the research discussed in this chapter was to isolate and characterise 
Affimers that bind to Z-disc proteins, for their suitability in dSTORM.  To achieve this, 
purified actin-binding domain (ABD) of human α-actinin 2 (α-Affimers) and the N-
terminal Z1/Z2 domains of titin (Z-Affimers) were used to screen for Affimers by phage 
display. 
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3.2 Method 
3.2.1 Expression and purification of human muscle α-actinin 2 - actin binding 
domain (ABD)  
The ABD cDNA construct within the E. coli expression vector pGEX-6p-1 was kindly 
provided by Dr. Marcin Wolny. The ABD (residues 1-269) with an N-terminal GST tag 
was expressed in BL21 (DE3) cells (400 mL culture), for 3 hrs at 37 ºC with 0.5 mM 
IPTG. After the protein was expressed the cells were first centrifuged (3,000 xg, 30 
mins), resuspended in 10 mL of ABD lysis buffer (1 mM DTT, 1mM EDTA, 200 µg/mL 
lysozyme, 0.1% Triton X-100) and then lysed by sonication. The cell debris was 
separated from the lysate by another centrifugation (30,000 xg, 45 mins). The ABD was 
first purified from the lysate by glutathione affinity chromatography. The lysate was 
added to a polyproplene 5 mL column (Qiagen) column with 2 mL of glutathione resin 
(amintra). The lysate was rolled with the resin in the column at room temperature for 20 
mins to allow the GST to bind the resin. The resin was then washed with 50 mL of 
PBS. 2 mL of precision protease buffer (20 mM Tris-HCl, 150 mM NaCl, pH 7.5) with 
20 µL of precision protease (with a GST tag) (~2 mg mL-1) was rolled with the resin 
overnight at 4 ºC to cleave the GST tag from the ABD. Following the precision protease 
treatment, the ABD was eluted off the column by washing the resin in 10 mL of 
precision protease buffer. The ABD was then exchanged in 50 mM NaCl, 20 mM Tris-
HCl, pH 8.0 using a vivaspin 20 concentrator (MWCO = 10 kDa) (GE healthcare) and 
concentrated down to 2 mL. 
To further purify the ABD sample anion exchange purification was used, using a 1 mL 
HiTrap Q FF (GE healthcare) column attached to an ÄKTA prime plus system (GE 
health care). The column was equilibrated in 50 mM NaCl, 20 mM Tris-HCl, pH 8.0. 
After the ABD sample was applied to the column, a NaCl salt gradient was set up over 
30 mL from 50 mM to 600 mM at a rate of 0.4 mL min-1 using the two buffers: Buffer A 
(20 mM Tris-HCl, pH 8.0) and Buffer B (1M NaCl, 20 mM Tris-HCl, pH 8.0) a salt 
gradient. 2 mL fractions were collected. The ABD was seen to elute off the column at ~ 
100 mM NaCl. After the purification the fractions were ran on an SDS-PAGE to assess 
the purity (Figure 3.1A).  The fractions with the purified ABD were pooled and dialysed 
against the 2L PBS overnight. 
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3.2.2 Expression and purification mouse Z1/Z2 domains 
The codon optimised Z1/Z2 cDNA for E. coli expression was synthesised and sub-
cloned into pET28a-SUMO by genscript. The Z1/Z2 domains (residues 1-200) with an 
N-terminal 6x His-SUMO tag were expressed in BL21 (DE3) cells (400 mL culture), for 
3 hrs at 37 ºC with 1 mM IPTG. After expression the cells were pelleted (3,000 xg, 30 
mins, 4 ºC), resuspended in 10 mL of lysis buffer (20 mM Tris-HCl, 150 mM NaCl, 20 
mM Imidazole pH 8.0) and lysed by sonication. Following this debris within the lysate 
was removed by centrifugation (30,000 xg, 4 ºC, 45 mins). The Z1/Z2 domains were 
initially purified from the lysate by nickel affinity chromatography. A gravity flow 
polyproplene 5 mL column (Qiagen) with 1 mL of cOmplete His-Tag purification resin 
(Roche) was used. After the lysate was applied to the resin, the resin was washed with 
50 mL of Z1/Z2 wash buffer (20 mM Tris-HCl, 500 mM NaCl, 20 mM Imidazole pH 8.0)   
SUMO protease with a 6x His-tag (~ 2 mg mL-1) in 2 mL of SUMO protease buffer (20 
mM Tris-HCl, 150 mM NaCl, pH 8.0) was incubated with the resin on a roller overnight 
at 4 ºC. The resin was then washed with 10 mL of PBS to elute the Z1/Z2 domains off 
the resin. The protein was further purified by size exclusion chromatography before use 
in the phage display assay. A Tricorn 10/200 gp column (GE healthcare) packed with 
Superdex 75 Prep Grade (GE healthcare) was used on an AKTA Prime plus system 
and equilibrated in PBS. 300 uL of the Z1/Z2 sample was loaded onto the column and 
30 mL of PBS was pumped through the column at a rate of 0.5 mL min-1.  Z1/Z2 
sample at each stage of the of the purification were taken for SDS-PAGE analysis 
(Figure 3.1B). For more efficient purifications of Z1/Z2 in the future, using more than 1 
mL of nickel resin to capture the Z1/Z2 domains from the lysate and incubating SUMO-
protease with the Z1/Z2 domains off the column, would be recommended. 
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3.2.3 Generating Affimers that bind the ABD and Z1/Z2 domains 
The phage display assays were performed by Dr. Christian Tiede. Biotinylated ABD 
and Z1/Z2 domains at a concentration of 0.5 mg mL-1 in PBS were separately used as 
protein targets for screening of an Affimer library by a phage display assay. These 
same purified proteins were additionally used to confirm that the Affimer clones 
obtained bound the targets in vitro by phage ELISA assay. The phage display assays 
were performed as previously described (Tiede et al. 2014, Tiede et al. 2017).  
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For the phage ELISA, the biotinylated targets were applied to streptavidin coated 
plates. Affimer phage bound to the target were detected by adding HRP anti-phage 
antibody (Seramun) and 3.3’,5,5-tetramethylbenzidine (TMB), then measuring the 
absorbance at 620 nm. Affimers clones that were found to bind the targets were then 
sequenced and sub-cloned in to pET11a for E. coli expression. 
3.2.4 Sub-cloning Affimer cDNA into pET11a 
The cDNA sequence for each Affimer was sub-cloned from the phagemid vector 
pBSTG1 into the protein expression vector pET11a (section 2.5.1 Figure 3.1C). The 
forward and reverse primers were used for the PCR can be found in Methods Table 2. 
The PCR mixture contained; 10 μL 5x Phusion polymerase HF buffer, 1 μL dNTP (10 
mM stock), 1.5 µL 100 % DMSO, 4 μL forward primer (10 μM stock), 4 μL reverse 
primer (10 μM), 1 μL pBSTG1- Affimer (10 ng µL-1), 1 μL Phusion High-Fidelity DNA 
polymerase (1.0 unit µL-1, NEB M0530S) and dH20 to make the final volume 50 μL. The 
PCR parameters using a BioRad T100 thermocycler are as follows: Initial denaturation 
at 98 ºC for 30 secs followed by 30 cycles of denaturation at 98 ºC for 20 secs, 
annealing at 54 ºC for 54 secs and extension 72 ºC for 20 secs and finished with a final 
extension at 68 ºC for 10 mins. 
After the PCR, the PCR product digested via incubation at 37 ºC for 2 hrs with 0.5 µL 
NotI-HF and 0.5 µL NheI-HF, 6 µL CutSmart Buffer and 3 µL dH2O (60 µL final 
volume). The Affimer cDNA inserts were then purified by gel electrophoresis and gel 
extraction (Methods 2.5.4). The cDNA inserts were ligated into linear pET-11a using 
T4 DNA ligase (NEB) (Methods 2.57) and was then transformed into NEB 5α cells 
(NEB, C2987I) (Methods 2.4) for subsequent minipreps (Methods 2.54) 
3.2.5 Purification of Affimers 
All Affimers were expressed in 200 mL cultures of BL21(DE3) cells using 0.1 mM IPTG 
for 6 hrs at 25 ºC. After the Affimers were expressed the cells were pelleted via 
centrifugation (3,000 xg, 30 mins), resuspended in 10 mL of Affimer lysis buffer (50 mM 
NaH2PO4, 300 mM NaCl, 20 mM imidazole, 10% glycerol, pH 7.4) and lysed by 
sonication. To denature low thermostable E. coli host proteins the lysates were heated 
at 50 ºC for 30 mins. Following this, debris within the lysate was removed by 
centrifugation (30,000 xg, 45 mins). All Affimers were purified by nickel affinity 
chromatography. The lysate was passed through a polyproplene 5 mL column (Qiagen) 
column with 1 mL of cOmplete His-Tag purification resin (Roche). 50 mL of Affimer 
wash buffer (50 mM NaH2PO4, 500 mM NaCl, 20 mM imidazole, 10% glycerol, pH 7.4) 
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was used to wash the resin in the column. The Affimer sample bound to the resin was 
eluted off with 5x 2 mL fractions of Affimer elution buffer (50 mM NaH2PO4, 500 mM 
NaCl, 300 mM imidazole, 10% glycerol, pH 7.4). For direct labelling of Affimers with a 
C-terminal cysteine, the fraction with the highest concentration of Affimer was used. 
For long term storage the fractions were then pooled and dialysed in PBS (or PBS with 
1 mM TCEP for Affimers with a C-terminal cysteine).  
α-Affimer 9 (no cysteine) was further purified by anion exchange chromatography for 
analytical size exclusion and crystal screens. A 1 mL HiTrap Q FF (GE healthcare) 
column attached to an ÄKTA prime plus system (GE health care) with the buffers 20 
mM Tris-HCl pH 8.0 and 1 M NaCl, 20 mM Tris-HCl pH 8.0. In the buffer conditions 50 
mM NaCl, 20 mM Tris-HCl pH 8.0, α-Affimer 9 did not bind to the column and were 
collected in the first two fractions (each 2 mL). The Affimer was then dialysed overnight 
in 2 L of the appropriate buffer. 
3.2.6 Labelling Affimers with commercial dyes 
All Affimers used as binders for fluorescence microscopy have a single C-terminal 
cysteine in the sequence before the 8x Histidine tag. The Affimers were linked to a biotin 
molecule, AlexaFluor 647 and Cy3b via the cysteine and maleimide. Freshly purified 
Affimers (straight from the column) was diluted in PBS to a concentration of                            
0.5 mg mL-1 (~ 40 µM). 150 µL of Affimer stock was added to 150 µL of TCEP immobilised 
resin (Thermo scientific, 77712) for 1 hr on a roller at room temperature. This was to 
make sure the Affimer was in reduced conditions before the introduction of the biotin/dye. 
Before addition of the Affimer, the TCEP resin was washed in PBS with 1 mM EDTA and 
6 µL of PBS with 10 mM EDTA was added. The resin and Affimer was centrifuged (2 
mins, 1,500 xg) and the 130 µL of Affimer sample was separated from the resin. Straight 
after this 6 µL of 2 mM biotin or dye was added to the Affimer and incubated for 2 hrs at 
room temperature on a roller (covered in the dark if a dye was used). A Zeba (MWCO 7 
kDa, 89882) desalting column was used to remove any free biotin/ dye from the Affimer 
sample. An SDS PAGE was ran of the dye labelled Affimers (Figure 3.2), the AF647 
linked Affimer ran at a higher MW compared to unlabelled Affimers for labelling efficiency 
to be assessed. For long term storage 130 µL of 80% glycerol was added to the sample 
(40 % final dilution) and all Affimers were stored at -20 ºC. 
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3.2.7 Staining adult rat cardiomyocytes  
The fixed cells plated on 13-mm diameter washed glass coverslips were permeabilised 
with 0.5 % Triton X-100 in PBS for 5 mins at room temperature. This was followed by a 
PBS wash (five washes in total). The cells were then blocked with BSA for 1 hr using 5 
% BSA in PBS. The cardiomyocytes were first stained with 50 µL of anti- α-actinin 2 
antibody (1:400) (Sigma, A7811, lot no. 024M4758) in 1 % BSA, incubated at room 
temperature for 1 hour. This was followed by a PBS wash (five washes in total). The cells 
were further co-stained with the Affimers directly linked to Alexa Fluor 647 (both α-
Affimers and Z-Affimers, 1 in 200 dilution) and α- mouse Alexa Fluor 488 antibody (Life 
Technologies A11059, lot no. 1348651, 1 in 500 dilution). The coverslips were mounted 
onto microscope slides using Prolong Gold Antifade (Life Technologies, P36934).  Cells 
were imaged using a 100x oil objective, on a DeltaVision Elite Microscope (GE 
Healthcare).  
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3.2.8 Size exclusion of Affimers, the ABD of muscle α-actinin and the N-
terminal Z1/Z2 domains 
A Tricorn 10/200 gp column (GE healthcare) packed with Superdex 75 resin attached 
to an ÄKTA Prime plus system was used for the size exclusion runs. 100 µL of protein 
samples were loaded onto the column for each size exclusion run. All protein samples 
were in PBS for runs involving α-Affimer 9 (no C-terminal cysteine) and all protein 
samples were in PBS with 1 mM DTT for runs involving Z-Affimer 12 (with a C-terminal 
cysteine). The column was equilibrated in either PBS or PBS with 1 mM DTT 
depending on the Affimer used for all runs. Affimer samples (40 µM α-Affimer 9 and 80 
µM Z-Affimer 12) and the targets (10 µM ABD and 40 µM Z1/Z2) were separately ran 
down the column and the UV absorbance of the elution volumes were measured. 
Affimers with the target proteins samples, α-Affimer 9 with ABD (40 µM : 10 µM) and Z-
Affimer 12 with Z1/Z2 (80 µM : 40 µM)   were incubated for 30 mins at room 
temperature before the size exclusion runs. 
The molecular weight of the protein species eluted off the column was estimated from 
runs using low molecular weight standards (Gel Filtration Calibration Kit, GE 
healthcare) (Figure 3.3). The elution volumes for each protein standards (where the 
UV absorbance was highest) were recorded and the Kav was calculated. 
Kav = (protein species elution volume – void volume) / (column volume – void volume) 
The column volume was 14.1 mL and the void volume, 6.08 mL, was measured by 
running dextran blue 2000 (1 mg mL-1) down the column and recording the elution 
volume. The Kav values of the standards were plotted against the logMW and a 
standard curve was plotted. Using the standard curve, the estimated MW of the protein 
samples were calculated. 
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3.2.9 X-ray crystallography structure of α-Affimer 9 bound to the ABD 
In a volume of 300 µL, ABD (75 µM) and α-Affimer 9 (135 µM) were incubated at room 
temperature for 30 mins. Size exclusion was used to separate the ABD:α-Affimer 9 
from free α-Affimer 9. The sample was loaded onto a Tricorn 10/200 gp column (GE 
healthcare) packed with Superdex 75 resin equilibrated in 75 mM NaCl, 20 mM Tris-
HCl pH 7.5. At a flow rate of 0.5 mL min-1, 1 mL fractions were collected. The fractions 
with the complex were pooled and concentrated to 60 µL for crystal screening using a 
vivaspin 6 (MWCO 3kDa) followed by a vivaspin 500 (MWCO 5 kDa), the final 
concentration was 7.2 mg ml-1. Crystals were obtained by sitting drop crystal screens 
vapour diffusion method using JCSG (Joint Centre for Structural genomics) Core 
Suites 1 and 2 (Qiagen). 1.2 µL of protein sample was added to 1.2 µL of each buffer 
conditions and the plates were incubated at 20 ºC. Crystals grew with 20 % w/v PEG 
3500 present.  Data was collected from a crystal that grew using the buffer conditions - 
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0.2 M (NH4)2 Tart, 20 % w/v PEG 3500 . This crystal belonged to spacing group P 
212121. 
3.2.10 Data collection and structure determination 
The data was recorded to a resolution range between 1.4 and 1.5 Å at 100 K on the 
macromolecular crystallography beamline station I04 at the Diamond Light Source by 
Dr Chi Trinh. The diffraction images were integrated, scaled and reduced using 3DII 
processing. The unit cell parameters obtained were a = 45.71 Å, b = 48.86 Å, c = 
147.19 Å, α = 90º, α = 90º and α = 90º.  5 % of the reflections from the data collected 
were selected at random and excluded from the refinement using the program 
FREERFLAG and constituted the Rfree set. The crystallographic structure of the α-
Affimer 9 : ABD complex was solved by molecular replacement using the programme 
PHASER  with the structures of the human wild type ABD from α-actinin 2 (PDB code  
5A38, 100 % sequence identity, Haywood et al. 2016) and a solved Affimer structure 
(PDB code 4N6T, Tiede et al. 2014) 
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3.3 Results 
3.3.1 Generating Affimers that specifically bind muscleα-actinin and the N-
terminal end of titin  
To generate Affimers, the ABD of muscle α-actinin and the N-terminal domains of titin 
(Z1/Z2) were cloned, expressed and purified and used as targets in separate phage 
display assays (Figure 3.1). Eight unique Affimer sequences for ABD (α-Affimers 1, 2, 
3, 4, 5, 9, 11 and 15) and seven for Z1/Z2 (Z-Affimers 2, 5, 7, 12, 17 and 21) were 
identified from the screens. A phage ELISA confirmed the Affimer sequences obtained 
bind ABD (Figure 3.4A) and Z1/Z2 (Figure 3.4B) in vitro. The Affimer sequences were 
then sub-cloned into pET11a (with a single cysteine present at the C-terminal end 
before the 8x His-Tag), for E.coli (BL21 DE3) expression. All the Affimers were 
expressed and purified to then be directly labelled with biotin. 
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3.3.2 Fluorescence imaging of adult rat cardiomyocytes labelled with α-
Affimers and Z-Affimers 
Three of the biotinylated α-Affimers (α-Affimers 1, 9 and 15) and four of the biotinylated 
Z-Affimers (Z-Affimers 2, 5, 7 and 12) showed positive staining of rat cardiomyocytes 
by fluorescence microscopy with streptavidin directly linked to Atto 488 (data not 
shown). The presence of distinctive, regularly spaced stripes were observed in positive 
staining. These are likely the Z-disc regions in the cells.  The remaining Affimers did 
not show positive staining (data not shown) in the cardiomyocytes, suggesting they 
cannot bind their targets in vivo. Either they are very weak binders, or they could not 
access their binding sites within the cell, or this might also be an effect of fixation 
conditions.  For dSTORM, the Affimers are directly labelled with a fluorescent dye on 
the cysteine, to reduce linkage error. The Affimers which had shown positive staining 
(when biotinylated) were directly linked with AlexaFluor 647 (AF647) to use for 
dSTORM imaging of cardiomyocytes. Fixed cardiomyocytes were stained with α-
Affimers 1, 9, 15 and Z-Affimers 2, 5, 7, 12 directly linked to AF647 and imaged by 
standard fluorescence microscopy to show the successful preparation of the Affimers 
before dSTORM (Figures 3.5A and B). Only α-Affimers 9 and Z-Affimer 12 showed 
the Z-disc stripped pattern expected, the other Affimers gave a high background 
fluorescence in the cardiomyocytes. One possible reason for is free dye in the Affimer 
samples and changes in the Affimer labelling protocol is required in the future. 
However, α-Affimers 9 and Z-Affimer 12 showed good staining and were therefore 
further characterised to determine their suitability for dSTORM. 
3.3.3 Size exclusion analysis of Affimers bound to their targets 
To confirm that the Affimers (non-dye labelled) are monomeric, and that they bind to 
their targets in vitro, size exclusion was used to assess the size of the Affimers and the 
stoichiometry of Affimers bound to their respective targets. After application of α-
Affimer 9 (40 µM) a single Affimer species eluted off the column (Figure 3.6A, red 
line). The MW was estimated from the elution point of the Affimer species and the 
elution points of known protein standards (Figure 3.6B). The estimated MW (3.6 kDa) 
of α-Affimer 9 is much smaller that the known MW (12.5 kDa). A possible explanation 
for this is that the Affimer interacts with the superdex 75 resin, resulting in the elution of 
the Affimer later than expected.  Therefore, the molecular weight of this Affimer cannot 
be reliably deduced by size exclusion chromatography. The ABD (10 µM) was applied 
to the same column (Figure 3.6A, blue line) and its estimated MW was calculated to 
be 34.7 kDa. This value is larger than the known MW (28.6 kDa). It is possible that the 
ABD is not entirely globular in nature causing it to elute off the column earlier than 
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expected (e.g. it has a slightly extended structure).   
Size exclusion was successful in confirming that α-Affimer 9 and its ABD target formed 
a 1:1 complex in vitro. Two different species eluted off the column. The first species is 
likely to be the ABD: α-Affimer 9 complex and the second, unbound Affimer 9, which 
was present in excess. SDS PAGE gel analysis of these two species (Figure 3.6C) 
confirmed that the first species contained both α-Affimer 9 and ABD and the second 
only contained α-Affimer 9.  The estimated MW of the complex (species 1) is 42.7 kDa 
(Figure 3.6B), which is very close to the MW of a 1:1 complex (41.1 kDa). This 
suggests that the complex contains a 1:1 ratio of α-Affimer 9 and the ABD target.  
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Size exclusion was also used to evaluate the Z-Affimer 12 : Z1/Z2 complex in vitro. The 
Z-Affimer 12 (80 µM) sample eluted off the column as one species (Figure 3.7A, 
orange line) and eluted much later than expected (Estimated MW = 6.1 kDa, Figure 
3.7B). The Z1/Z2 domains sample on the other hand (Figure 3.7A, magenta line) 
eluted off the column earlier than expected for a 21.3 kDa globular protein (Estimated 
MW = 31.2 kDa, Figure 3.7B). The linker region between the two Ig domains Z1 and 
Z2 is highly flexible which allows for different conformations of the Z1/Z2 domains 
(Marino et al. 2006). Therefore, the Z1/Z2 domains may have an extended 
conformation, that results in an earlier elution compared to a globular protein of the 
same size. Size exclusion chromatography of the complex of Z1/Z2 with Z-Affimer 12 
(1:2 molar ratio) (Figure 3.7A, blue line) suggested that a 1:1 complex is formed in 
vitro. Two species elute off the column. An SDS PAGE of the elution volume confirms 
that species one is the Z1/Z2: Z-Affimer 12 complex (Figure 3.7C) and species 2 is 
free unbound Z-Affimer 12. Both the difference in estimated MW (Figure 3.7B) 
between Z1/Z2 and the complex (species 1), ~ 12 kDa, and free excess Z-Affimer 12 is 
present together confirms a 1:1 complex. 
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3.3.4 Heating of α-Affimer 9 to 50 ºC does not cause misfolding or 
aggregation 
The protocol for the purification of Affimers involves a heat denaturing step at 50 ºC for 
30 mins to remove any low thermostable E. coli host contaminant proteins present in 
the sample. The scaffold Affimer sequence is highly thermostable (Tm = 101 ºC) 
(Tiede et al. 2014), however with variable binding loops this may not be the case for all 
Affimers. Two separate sample of pure α-Affimers 9 were prepared; one with the heat 
denaturing step and one without the heat denaturing step. Size exclusion was used to 
assess if there was an increase in aggregation of α-Affimer 9, caused by the heat 
denaturation step. There were no noticeable differences between the elution profiles of 
the two samples (Figure 3.8), suggesting the heat step did not cause unfolding of α-
Affimer 9 or aggregation. However, the exact thermostability of α-Affimer 9 and Z-
Affimer 12 have yet to be determined. It should also be noted for purification of α-
Affimer 9 without a C-terminal cysteine a heat denaturation step is not required. For 
direct labelling of Affimers using the C-terminal, the Affimer is labelled after the nickel 
affinity chromatography step and the heat denaturing step is required for a purer 
sample. 
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3.3.5 Crystal structure α-Affimer 9 bound to the ABD 
The X-ray crystallographic structure for the α-Affimer 9 : ABD complex was solved at a 
resolution of 1.4 Å (Figure 3.9A) . The ABD is in a “closed conformation” as seen in all 
human ABD crystal structures of α-actinins, whereby there are contacts between the 
two CH domains. Both binding loops 1 and 2 of α-Affimer 9 are packed in against the 
helix E of the CH2 domain of the ABD (Figure 3.9B). The larger loop 2 is the primary 
binding loop which has most contact with the CH2 domain. At the C-terminal end of the 
CH2 α-helix E there is hydrogen bonding between the amine group of K222 of the helix 
and D109, the backbone of N111 and F112 (Figure 3.9C). Also, H223 of the α-helix 
forms hydrogen bonding with F112 on binding loop 2. Only one hydrogen bond 
interaction forms between the α-helix of CH2 and the smaller binding loop 1 (Figure 
3.9D), between W74 and the backbone of G211. The Affimer is not bound near any 
known actin binding sites so is unlikely to inhibit the ABD : actin interaction. However, 
the ABD with the Affimer bound did elute as a more globular species compared to the 
ABD alone in size exclusion chromatography (Figure 3.6). Thus, the Affimer may still 
have an inhibitory effect on the ABD as an increase transitional energy may be require 
to go between the closed and open conformations. Also, the Affimer binding site is not 
situated near the hypothesised PIP2 binding site (R163, R169 and R192) and is unlikely 
to inhibit PIP2 regulation of α-actinin.  
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3.4 Discussion 
Unique Affimers that bind proteins within the Z-discs of striated muscle cells were 
successfully raised and tested. Of the eight Affimers tested for the ABD of α-actinin 2, 
three successfully labelled the Z-disc in adult rat cardiomyocytes, with α-Affimer 9 
showing the best staining.  Of the seven Z-Affimers tested for the Z1Z2 domain of titin, 
four Affimers successfully labelled the Z-disc in both samples, and Z- Affimer 12 
showed the best staining. Size exclusion chromatography of these two Affimers 
demonstrated that they both formed 1:1 complexes. Also, a crystal structure of α-
Affimer 9 with ABD revealed the loop 2 of the Affimer is the major binding loop and 
forms contacts with the E helix of the CH2 domain. 
Affimers are a strong alternative to antibodies.  A number of Affimers have already 
been shown to work well for fluorescence microscopy (Tiede et al. 2017, Lopata et al. 
2018) for a variety of targets. Their small size, and the ability to directly label the 
Affimers with a single fluorescent dye molecule, allows them to penetrate dense 
cytoskeletal regions such as the Z-disc in muscle cells and places the fluorophore 
close to the target protein. In contrast antibodies are large and using a combination of 
both primary and secondary antibodies can restrict access of antibodies, and 
additionally places the fluorophore at some distance from the target protein, increasing 
the ‘linkage’ error in super-resolution microscopy. Our results with the Z-disc Affimers 
demonstrates that they can be raised successfully to Z-disc proteins, and their small 
size should be an advantage for super-resolution microscopy approaches. 
A possible reason why only three of the eight α-Affimers generated to the ABD of α-
actinin-2 and only four of the seven Z-Affimers generated to the Z1/Z2 domains is that 
the epitopes that they recognise and bind to in fixed cells are not available, as they 
form part of the binding sites with other proteins. The ABD of muscle α-actinin binds 
actin filaments and the Z1/Z2 domains are bound to the titin capping protein telethonin 
(Gregorio et al. 1998). Equally, this approach also demonstrates that unique Affimers 
can be isolated to epitopes that are not blocked.  This is very promising for generating 
Affimers in the future for fluorescence microscopy work investigating Z-disc proteins or 
for proteins that localise in equally dense networks.  
Size exclusion chromatography showed that α-Affimer 9 and Z-Affimer 12 were both 
monomeric in solution and that they bound to their respective target to form a 1:1 ratio 
complex.  This confirms that these Affimers have the potential to work well in dSTORM 
as a single Affimer will be bound to a single target molecule, with a single dye label 
 
 
60 
 
indicating its position in dSTORM. This shows that the Affimers chosen are suitable for 
dSTORM.  Although I did not determine the binding affinity of the Affimers with their 
targets, the majority of Affimers bind to their target protein with high affinity (nanomolar 
range Tiede et al. 2016). The formation of a complex in the size exclusion experiments 
does indicate relatively strong affinity between the Affimer and its target.  
Both the α-actinin 2 ABD and the titin Z1/Z2 proteins eluted earlier than expected from 
the size exclusion chromatography, suggesting that they may both have an extended 
conformation. The crystal structure of telethonin bound to the Z1/Z2 domains shows 
telethonin sandwiched by the two Z1/Z2 domains, with the Ig domains of Z1Z2 showing 
an extended structure (Zou et al. 2006). This extended structure is thought to be 
similar to the preferred conformational state of the Z1/Z2 domains free in solution, 
however other conformations are possible via the flexibility in the linker loop (Marino et 
al. 2006).  
The ABD of α-actinin is also two globular domains (CH1-CH2) connected by a small 
linker loop. However, it is generally considered that the ABD of all α-actinins are in a 
closed conformation and then adopt a more open conformation when bound to actin 
(Galkin et al. 2010, Franzot et al. 2005). Previous crystal structures of the α-actinin 
ABD and the crystal structure here (Figure 3.9A) shows the ABD in a globular “closed 
conformation” whereby the two CH domains form contacts with one another. Analytical 
Ultracentrifugation (AUC) of the ABD from non-muscle α-actinin 4 (at 20 and 37 ºC) 
indicates that the ABD is in the closed conformation when free in solution (Lee et al. 
2008). However, the size exclusion run of the ABD from muscle α-actinin 2 shows ABD 
sample elutes off the column earlier than expected of a globular protein of the same 
size (Figure 3.6A and B). The elution profile of the ABD sample is similar to that of the 
Z1/Z2 domains. This suggest the ABD population is not globular and may adapt a more 
open conformation. This is surprising as the residues within the interface of the CH 
domains are highly conserved between the different isoforms of human α-actinins (see 
section 1.2.2). However, the size exclusion runs were conducted at 4 ºC, not 
physiological temperature, which could account for the differences observed and the 
ABD eluted off the column as a globular species with α-Affimer 9 bound. The size 
exclusion chromatography only indicates the ABD population is not globular compared 
to protein standards (GE Healthcare), further experimentation such as AUC would be 
required for the ABD from muscle α-actinin 2. 
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 Chapter 4 – Arrangement of α-actinins and the N-terminal 
ends of titin in the Z-disc 
4.1 Introduction   
Within the Z-disc lattice structures of striated muscle cells the arrangement of α-actinin 
is thought to be ordered along the actin filaments (the axial direction of the cells). As 
discussed in section 1.2, along a single actin filament layers of α-actinin are spaced 
19.2 nm apart and following the 43 screw symmetry of the actin, rotated 90 º from each 
other (Figure 4.1A).  Each layer comprises of pair of α-actinin molecules spaced 2.74 
nm apart (a single G-actin subunit) and orientated 167.4 º away from each other on the 
filament. In slow muscle, six α-actinin layers have been observed by EM (Luther et al. 
2002).  There can however be variation in the spacing between bound α-actinin on 
different actin filaments (transverse directions) due to the heterogeneity of the Z-disc 
lattice conformation (small square and basket weave). The lattice spacing for the small-
square lattice conformation within cardiac muscle has been reported to be 20 - 30 nm 
(Goldstein et al. 1989, Burgoyne et. al 2015) (Figure 4.1B). A 20 % increase in 
lattice spacing has been reported for the basket weave conformation (Goldstein et al. 
1989). By X-ray diffraction both conformational states are seen to present in the Z-
discs of rabbit psoas muscle no matter if the muscle sample is tense or relaxed (Pres-
Edward et al. 2011). However, the ratio between these conformational states in the Z-
discs depends on the state of the muscle.  
It is unclear where the N-terminal Z1/Z2 domains are localised in the Z-disc. There 
have been conflicting results from different studies investigating the localisation of 
Z1/Z2 domains by immuno-EM. One indicates titin starts at the edge of the Z-disc 
region (Gregorio et al. 1998) in human soleus muscle whilst the other indicates that 
titin starts well within the Z-discs (Gautel et al. 1996). In these cases, different 
antibodies that bind Z1/Z2 domains of titin were used on different muscle tissues, 
which could account for the discrepancy of the results observed. Also, as mentioned 
earlier (section 3.1), the labelling efficiency of antibodies, especially when bound to 10 
nm nanobead gold particles within the dense cytoskeletal network of the Z-discs is 
questionable due to the antibody size. Two Z1/Z2 domains from separate titin chains 
are thought to be cross-linked by telethonin to form a palindromic complex (Zou et al. 
2006, PDB code 1YA5). Both the Z1/Z2 domain and telethonin co-localise in the Z-
discs of neonatal rat cardiomyocytes and in four day differentiated human skeletal 
myofibrils as demonstrated by immunofluorescence microscopy (Zou et al. 2006, 
Mues et al. 1998). As the Z-repeats of titin are thought to interact with α-actinin, the 
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Z1/Z2 domains have been modelled at the end of the actin filaments in the Z-discs 
(Zou et al. 2006).  
 
In the previous chapter, Affimers were generated to bind both α-actinin 2 (CH domains) 
and the N-terminal domain of titin. In this chapter, dSTORM will be used with the 
Affimers to obtain localisation information for α-actinin and the Z1/Z2 domains within 
the Z-discs of cardiomyocytes. The localisation data will be further analysed by a novel 
form of pattern analysis.  Studies of how these proteins are arranged within the Z-discs 
have mainly relied upon finding the binding partners of these proteins, not microscopy 
techniques. Studying the arrangement of α-actinin in the Z-disc by dSTORM first, 
before other Z-disc proteins, acts as a proof of principle for the technique. The regular 
arrangement observed in EM studies should also be seen by dSTORM. The 
arrangement of the N-terminal end of titin in the Z-disc lattices is less certain, therefore 
using super-resolution fluorescence should shed light on how the domains localise in 
the Z-discs.  
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4.2 Methods 
4.2.1 Staining adult rat cardiomyocytes for dSTORM imaging 
Adult rat cardiomyocytes seeded onto 25 mm coverslips (cleaned as described 
Schierle et al. 2011) were either stained with α-Affimer 9 or Z-Affimer 12 directly linked 
to Alexa Fluor 647 (AF647). The cardiomyocytes were first permeabilised using Triton 
X- 100 in PBS (0.5 % for labelling with α-Affimer 9 and 0.2 % for labelling with Z-
Affimer 12) and incubated at room temperature for 5 mins, then washed in PBS. The 
cardiomyocytes were then blocked with 5 % BSA in PBS at room temperature for 1 hr. 
The Affimers were diluted in 1 % BSA in PBS before incubation with the 
cardiomyocytes at room temperature for 1 hr in the dark. A dilution of 1 in 750 of α-
Affimer 9 was used (Final concentration ~ 0.6 µg mL-1) and a dilution of 1 in 500 of Z-
Affimer 12 was used (Final concentration ~ 1 µg mL-1). 
The coverslip was mounted into a chamber suitable for the 3D STORM microscope (as 
described in Section 2.10). The coverslips were incubated with 0.01 % poly-l lysine 
(Sigma Aldrich, P4707) for 10 minutes at room temperature, then 200 l of 150 nm 
diameter gold fiducials (Sigma Aldrich 742031, diluted 1/10 from stock supplied from 
the manufacturer) were applied to the sample and allowed to settle on the coverslip.  
Excess fiducials were then removed, and the imaging buffer was added to the 
chamber. The STORM buffer contained, 10 % glucose (w/v), 0.5 mg ml-1 glucose 
oxidase, 80 μg ml-1 catalase, 110 mM β-mercaptoethanol, PBS pH 8.0). 
4.2.2 dSTORM image acquisitions and 3D histogram reconstruction 
The workflow for dSTORM image acquisition followed that published (York et al. 2011) 
(see https://github.com/AndrewGYork/palm3d for further details) and included capture 
of a calibration image stack of a selected 150 nm gold nanoparticle in steps of 50 nm in 
z over a 4 micron range. The fluorescent dyes (Alexa Fluor 647) in the sample were 
excited using a 642 nm laser (100 mW), until a sufficient number were quenched 
(Heilemann et al. 2009, 2008) for spatially nearby emission events to be separated in 
time, following which we began data collection (exposure time 50 ms, EMCCD gain 
150). When fluorescent events appeared to dye down a 405 nm laser with increasing 
power from 2 to 20 mW was used to re-activate the fluorophores. Fluorescent events 
lasting for more than one frame were linked into averaged localisations, which were 
finally binned into a histogram for display, accounting for distortion by the cylindrical 
lens. All the localisation co-ordinates collected in a single field of view were binned 
together in a final histogram. 
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4.2.3 Constructing 3D relative position density histogram  
The 3D relative position density (RPD) histograms were generated by scripts created 
by Dr. Alistair Curd and ran in SPYDR. The 3D RPD histograms were generated by: (1) 
Aligning the 3D dSTORM cardiomyocyte reconstructions.  Every 2D dSTORM 
reconstruction of labelled cardiomyocytes was rotated so that the cell axis is pointed 
along the x. This allows for dSTORM localisation datasets from different 
cardiomyocytes to be combined as the 3D relative position data were in the same co-
ordinate system across all cardiomyocytes. For the 3D RPD histogram the x axis 
represents the axial direction of the cell and the y and z axis both represent the 
transverse plane of the cell. (2) Filtering of localisations based on localisation 
precision. Only localisations with a localisation precision less than or equal to 5 nm 
were used (Figure 4.2A and B). The localisation precision for each localisation was 
estimated using the equation - σ / √N, the standard error on the localisation precision.  
N is the number of photons emitted from each fluorescent event above background. σ 
is the mean of the two widths from a 2D gaussian fit from the relevant image from the 
calibration stack of the nano-gold particle. (3) Plotting the 3D RPD histogram. 
Relative positions are the distances between pairs of localisations. In turn, every 
localisation in the dSTORM histogram is assigned the co-ordinates (0, 0, 0 in x, y and 
z) then all neighbouring localisations (within a certain range) are plotted per nm in the 
3D histogram. The range used in this case was 140 nm as the width of the Z-discs in 
cardiomyocytes have been reported to be 100 – 140 nm (Luther et al. 2003). The final 
density observed in the histogram is the relative position counts per nm. (4) 
Generating 1D relative position density profiles. To better visualise the pattern in 
the 3D relative position density histogram (RPD) and thus analyse the data, 1D RPD 
were generated for the axial direction and the transverse planes. The relative position 
density in the axial direction of the 3D RPD histogram, within the range of 0 – 10 nm in 
the transverse planes was plotted. Likewise, the relative position density in the 
transverse planes of the 3D RPD histogram, within the range of 0 – 10 nm in the axial 
direction was plotted. 
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4.3 Results  
4.3.1 Imaging adult rat cardiomyocytes by dSTORM using α-Affimer 9 and Z-
Affimer 12 linked to AlexaFluor 647 
To obtain localisation information for α-actinin 2 and the N-terminal ends of titin in the 
Z-discs of adult rat cardiomyocytes by dSTORM, the fixed cells seeded on coverslips 
were separately labelled with α-Affimer 9 and Z-Affimer 12 directly linked to Alexa Fluor 
647 (AF647). dSTORM involves rapid imaging the same field of view (FOV) whilst the 
AF647 dyes are activated via an excitation laser (642 nm wavelength, 100 mW).  Fields 
of view which had a single cardiomyocyte and at least one fiducial marker (for image 
drift tracking) were chosen for imaging (Figure 4.3A and B).  Whilst the excitation laser 
is on, the AF647 dye population are constantly cycling between photon emitting and 
dark states, due to the dye quenching buffering conditions of the cells during imaging 
(Heilemann et al. 2009, 2008). Only a sub-set of the AF647 dyes are activated within 
the cardiomyocytes at any one time. Therefore, each image taken of the FOV captures 
sparsely activated individual fluorescent events. The localisation co-ordinates for each 
of the fluorescent events (in x, y and z planes) are then determined from all the images 
and are plotted in the final 3D histogram.  
The 3D dSTORM reconstruction of single cardiomyocytes labelled with either α-Affimer 
9 (Figure 4.3C) or Z-Affimer 12 (Figure 4.3D) showed the regular Z-disc striped 
pattern (shown as 2D plots, projected in z). At 100 nm binning of localisation points, the 
histograms are comparable to cardiomyocytes stained with the Affimers imaged by 
conventional fluorescence microscopy techniques. Low levels of localisations outside 
of the Z-discs were seen, thought to be caused by non-specific binding of Affimers 
together with background auto-fluorescence of the cardiomyocytes. When the 
localisations were binned together over a smaller distance (10 nm) (Figure 4.3E and 
F), the localisations within the Z-disc regions could be seen. However, analysing the 
localisation dataset in this format to gauge the arrangement of the Z-disc proteins can 
be problematic. There are two main reasons for this: (1) The labelling efficiency of the 
Affimers is not 100 % and not all of the target Z-disc proteins were labelled within the 
cardiomyocytes. (2) The localisation precision, the precision at which the co-ordinates 
for each fluorescent event is plotted, were different for each localisation (Figure 4.2A 
and B). For a sub-set of localisations collected per field of view, the localisation 
precision was not of a quality to resolve the arrangement of protein in the Z-discs. 
Therefore, further analysis of the dSTORM dataset was required to determine the 
arrangement of α-actinin and the N-terminal ends of titin in the Z-discs. 
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4.3.2 Using PERPL analysis to determine the arrangement of α-actinins in 
the Z-discs 
The localisations datasets for α-actinin in cardiomyocytes were then further analysed 
using PERPL (patterns extracted from relative positions of localisations), developed by 
Dr. Alistair Curd, University of Leeds (currently unpublished). PERPL analysis involves 
generating a 3D relative position density (RPD) histogram (see Methods 4.2.3) from 
localisation pairs in the dSTORM datasets and analysing the pattern in the histogram. If 
there is a regular arrangement of a target protein in vivo, there would be common 
distances between pairs of localisations (relative positions) in the dSTORM dataset and 
a pattern in the 3D RPD histogram would be observed. For this analysis 100 % 
labelling efficiency of the Affimer is not required, datasets from different FOV can be 
combined into the same 3D RPD histogram and localisation data used can be filtered 
based upon localisation precision. 
For the analysis of the arrangement of α-actinins in the Z-discs, dSTORM localisation 
datasets from three different fields of view of single cardiomyocytes labelled with α-
Affimer 9 were collected. These datasets were initially combined (total number of 
localisations ~ 135,000), and a localisation precision cap of 5 nm was used (Figure 
4.2A) as most of the dataset was retained, whilst the resolution of the data is off a 
quality to discern the arrangement of the α-actinin in the Z-discs. The 3D RPD 
histogram generated from the combined dSTORM datasets (Figure 4.4A), shown here 
as a 2D representation) clearly shows the highest RPD between 0-20 nm in the axial 
direction, the RPD dissipating the further along the axial direction and a weak to no 
RPD signal past 100 nm (Figure 4.4A). The Z-discs in cardiomyocytes are ~ 100 nm 
wide, it was therefore not unexpected for there to be weak to no RPD past 100 nm. 
Also, it was not unexpected for RPD to dissipate the further along in the axial direction. 
For each six layers of α-actinins regular spaced on an actin filament (in the axial 
direction, Figure 4.1) there will be more relative positions between pairs of α-actinins 
closest together (~ 19.2 nm) compared the relative positions of furthest apart from one 
another (~ 96 nm). However, from the 3D and 2D RPD histogram plots alone it is hard 
to discern a pattern as there is a high background. 
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To better visualise the RPD pattern above background in the histogram, 1D RPD 
profiles were generated for the axial direction of the cell and the transverse plane of the 
cell (Figure 4.4B, See methods 4.2.3).  In the axial direction the 1D RPD profile was 
expected to show high relative position densities above background at 19.2, 38.4, 57.6, 
76.8 and 96 nm, representing the 19.2 nm spacings between the six α-actinin layers in 
the Z-discs. The axial profile shows three distinct high RPD peaks 18, 34 and 57 nm, 
representing a repeating spacing pattern of α-actinin of ~ 18 nm. This is very similar to 
the expected spacing (~ 19.2 nm) and a clear repeating pattern can be seen. The ~ 1 
nm difference in α-actinin spacing observed in previous EM studies and the spacing 
seen here could be due to the limitations of the localisation precision. Also, there were 
three distinct peaks in the RPD profile not five peaks representing spacing between six 
layers of α-actinins. As previously stated, there are fewer relative positions between α-
actinins spaced further apart along the actin filament in the dataset. In the axial profile 
the RPD significantly reduced after ~ 60 nm in the axial direction and there is no 
discernible pattern. The collection of more dSTORM data would be required to better 
show the RPD pattern past 60 nm in the axial direction.  
The greatest RPD in the transverse plane profile is at 11 nm (Figure 4.4B). One 
possibility for this is the spacing between the two actin binding domains of the same α-
actinin layer bound to the same actin filament (~10 nm in the transverse planes, Figure 
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4.1). However, the relative positions between actin binding domains in the same layer 
(separated 2.74 nm apart) were not observed in the axial direction RPD profiles. With 
the localisation precision of the datasets (≤ 5 nm) it is unlikely that small relative 
positions will be resolved. The high RPD at 11 nm could also represent the spacing 
between α-actinin ABD bound to actin filaments from different sarcomeres. The 
distance would be ~14 nm if the lattice spacing is ~ 20 nm (Figure 4.1). This spacing 
could be observed as 11 nm in the profile because of the linkage error of α-Affimer 9 (~ 
3 nm). The transverse planes profile also shows a repeating pattern of ~20 nm. There 
are peaks above background at ~ 20, 39, 58 and 84 nm. This pattern could be the 
lattice spacing, the spacing between actin filaments from the same sarcomere (~20 
nm, Goldstein et al. 1989). However, there is not a distinct peak at 20 nm. The profile 
also does not show the presence of two different conformations of Z-disc lattice present 
in the cardiomyocytes (small square and basket weave). It can be argued the 
localisation precision of the dSTORM dataset is too poor to show the different 
conformations if they were both present in the cardiomyocytes imaged.  
PERPL analysis was also used for each individual FOV α-actinin dSTORM dataset in 
addition to the combined dataset to gauge any variation between cardiomyocytes 
(Figure 4.5, PERPL analysis). The difference in number of localisations for each 
dataset varied widely, and this was due to a different number of acquisitions for each 
dataset; 7 for FOV 1 (Figure 4.5A ~ 100,000 localisations) and only 1 for FOV 2 
(Figure 4.5B ~ 24,000 localisations) and FOV 3 (Figure 4.5C ~ 6,000 localisations). 
The labelling efficiency of the α-Affimer 9 could also had been a factor in the different 
size datasets. It is clear as the FOV 1 dataset contains many more localisations 
compared to FOV 2 and 3, therefore the RPD profiles for FOV 1 (Figure 4.5A) is 
similar to the profiles of the combined dataset (Figure 4.5D). The axial direction RPD 
profile of the FOV1 dataset even shows five peaks above background representing. It 
can be argued PERPL analysis of a single FOV dSTORM dataset can be used to 
reliably determine the protein arrangement. Despite FOV 2 and 3 having smaller 
localisation dataset, patterns in the 1D RPD profiles could be seen (Figure 4.5B and 
C).  However, the patterns observed on the FOV2 and FOV3 RPD profiles deviate from 
the pattern expected from the known arrangement of α-actinins in the Z-disc (from EM 
studies). Also, the RPD profiles in the axial direction for the different fields of view are 
not consistent with one another. The RPD profiles generated from FOV2 and 3 
highlight the need for large localisation datasets (similar to FOV 1) for reliable PERPL 
analysis.  
 
 
71 
 
 
 
 
72 
 
4.3.3 Using PERPL to analyse the arrangement of the N-terminal Z1/Z2 
domains of titin in the Z-discs of titin 
dSTORM localisation datasets from three different FOVs of single cardiomyocytes 
labelled with Z-Affimer 12 were collected and PERPL analysis was used for the 
combined dataset (~ 12,600 localisations) (Figure 4.6A and B). The size of dSTORM 
localisation datasets for each FOV were small (Figure 4.2B). Only 2-3 acquisitions 
were collected for each field of view before the AF647 dye population was bleached. 
This could be due to poor labelling efficiency of the Z-Affimer 12. Alternatively, this 
could be due to a lower number of available binding sites, there are thought to be only 
two Z1/Z2 domains per actin filament in the Z-discs compared to twelve α-actinin 
molecules.  Despite this, a pattern was observed in the 3D RPD histogram generated 
(Figure 4.6A). Similar to the α-actinin RPD histogram (Figure 4.4A), weak to no RPD 
signal past 100 nm. The 1D transverse planes RPD profile shows high RPD at 24, 49, 
75 and 107 nm (Figure 4.6B) suggesting regular spacing of ~ 25 nm between Z1/Z2 
domains of titin from the same sarcomere. It could be argued this is the same as the 
lattice spacing of the actin filaments. The 1D profile in the axial direction shows high 
relative position density above background at 20, 33, 63, 84 and 100 nm. This suggest 
the Z1/Z2 domains are not only at the edges of the Z-discs but are arranged throughout 
the Z-disc in the axial direction with no clear ordered arrangement. The relative 
positions of 100 nm could be the spacing between Z1/Z2 domains at the edges of the 
Z-discs and the relative positions of 20 nm could be Z1/Z2 domains positioned 10 nm 
from the centre. From the data here it is unclear if titin is anchored at different positions 
the Z-discs in the axial direction or titin filaments capable of sliding in the Z-discs. 
However, a larger dataset would needed to better answer this question. 
It is thought that the Z1/Z2 domains of two titin molecules from the same sarcomere 
are crosslinked in a palindromic complex at the end of the actin filaments (Zou et al. 
2006). The crystal structure of Z-Affimer 12 bound to the Z1/Z2 domains has yet to be 
solved. If two Z1/Z2 domains molecules are bound to telethonin (2:1 ratio) in 
cardiomyocytes in a palindromic complex the furthest distance the Z-Affimer 12 can be 
from each other is 11 nm (measured between the two Z2 domains in the Z1/Z2 : 
telethonin crystal structure, PDB code 1YA5, Zou et al. 2006). The transverse profile 
does show a high above background RPD at 5 nm (Figure 4.6B), which may 
correspond to the spacing of Z1/Z2 domains cross-linked by telethonin. However 
common relative positions below 20 nm were not seen in the axial profile. There could 
be due to Z-Affimer 12 only binding to one Z1/Z2 domain per complex or the spacing 
between two Z1/Z2 domains bound to telethonin is too small for the relative positions to 
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be resolved.  Alternatively, the 2:1 ratio Z1/Z2 to telethonin seen in the crystal structure 
may not occur in vivo. Assuming the Z1/Z2 domains of two titin filaments from the 
same sarcomere are cross-linked by telethonin, the relative positions shown in the 
RPD axial plots are likely to be between titin filaments from adjacent sarcomeres 
separated at the most by 10 nm in the transverse plane. The N-terminal domains of titin 
from the same sarcomeres are spaced too far away from each other in the transverse 
plane (~ 25 nm) for the relative positions of the Z1/Z2 localisations to be seen in the 
axial RPD plot.  
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PERPL analysis was also used for the individual FOV dSTORM datasets which make 
up the combined dataset, to gauge if there are any variations between the different 
cardiomyocytes (Figure 4.7A, B and C). Like PERPL analysis of the α-actinin 
dSTORM dataset it is clear the 1D RPD profiles of the combined dataset is most 
influenced by the FOV with the largest dataset, in this case FOV 2 (~ 7,000 
localisations). It could be argued that the other fields of views (FOV 1 and 3) also show 
the 25 nm spacing pattern clearly seen in the FOV 2 transverse planes profile, however 
not as well. Interestingly the axial profile for FOV 3 (Figure 4.7C) shows high RPD at 
17 and 100 nm. Also, the highest RPD for the FOV 1 in the axial profile is at 6 nm, 
which is not seen in the other fields of view. This may correspond to the spacing 
between two Z1/Z2 domains crosslinked by telethonin. However, with the small dataset 
sizes it is unclear if the patterns seen in the 1D profiles are common Z1/Z2 relative 
positions or simply background noise. Further Z1/Z2 localisations need to be collected 
to reliably determine the spacing of the N-terminal domain titin in the Z-discs.  
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4.4 Discussion 
One of the aims of this chapter was to determine if dSTORM is a suitable technique to 
reliably show the arrangement of proteins within the Z-discs of cardiomyocytes. From 
EM studies, the arrangement of α-actinin molecules is well understood.  α-Affimer 9 
directly linked to AF647, which binds α-actinin, was used to label adult rat 
cardiomyocytes and imaged by dSTORM. From the dSTORM reconstructions alone, it 
was difficult to determine the arrangement of α-actinin due to the localisation precision 
of the dataset and the labelling efficiency of α-Affimer 9. Therefore, only a sub-set of 
dSTORM localisations (5 nm localisation precision cut-off, Figure 4.2A) was used for 
further PERPL analysis to look for common spacing between localisations. In the axial 
direction (along the actin filaments) repeat spacing of 19.2 nm was expected. The RPD 
profiles in the axial direction (Figure 4.4B) did show regular spacing along the actin 
filaments. Also, the RPD profiles of the transverse plane did show the spacing of ~20 
nm, possibly following the lattice spacing of the Z-disc. Also, FOV1 (Figure 4.5A) 
showed the relative positions for ~10 nm, the distance between two actin binding 
domains in one α-actinin layer bound to the same actin filament or the distance 
between actin binding domains of opposing actin filaments. 
The results from the dSTORM/α-Affimer 9 localisation dataset show the potential for 
the use of dSTORM with PERPL analysis for the arrangement of Z-discs protein in 
cardiomyocytes. From the analysis of α-actinin localisations in this chapter, it is clear 
that good labelling of the cardiomyocyte with the Affimer is key. dSTORM imaging of 
one well labelled sample as in FOV1 (Figure 4.5A) reliably showed the arrangement of 
α-actinin. Why one field of view showed better labelling with the Affimer however the 
other is unclear. The localisation precision cut-off used for PERPL analysis used in this 
work was 5 nm, to retain a larger proportion of the dataset. As a result, the spacing of 
α-actinin less than 10 nm apart were not observed. Also, any heterogeneity in α-actinin 
arrangement caused by the heterogeneity in Z-disc lattice conformations was not 
observed. For analysis of Z-discs proteins in the future, a larger dataset would need to 
be collected and a smaller precision localisation cut-off (e.g. 2 - 3 nm) could be used 
for PERPL analysis to give a more detailed view of the arrangement of proteins in the 
Z-discs. 
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With dSTORM successfully showing the arrangement α-actinins, the same procedure 
was used to analyse the arrangement of the N-terminal domains of titin (Z1/Z2) in the 
Z-discs of cardiomyocytes.  PERPL analysis of dSTORM/Z-Affimer 12 localisation data 
clearly showed regular 25 nm spacing of Z1/Z2 domains from the same sarcomere in 
the transverse directions of the Z-disc lattice (Figure 4.6B), consistent with its 
organisation following that of the actin filaments. However, the α-actinin dSTORM 
suggested actin lattice spacing of 20 nm. To more confidently determine the actin 
filament lattice spacing in the Z-discs, the same dSTORM protocol can be used for the 
actin capping protein CapZ. It was previously suggested that the N-terminal end of titin 
only localised at the edges of the Z-discs (Gregorio et al. 1998). Here dSTORM and 
PERPL analysis shows the Z1/Z2 domains are distributed throughout the Z-disc not the 
edges, supporting what was seen by immuno-EM in another study (Gautel et al. 1996). 
Moving forward a larger dataset is required for a more comprehensive analysis. The 
dSTORM dataset used here (Figure 4.2B) was very small and so the localisation 
precision of the dataset analysed was ≤ 5 nm. Also, it would be interesting to see if 
using the dSTORM/PERPL analysis technique for telethonin shows the same 
arrangement in the Z-discs as the Z1/Z2 domains. From the work in this chapter, it is 
clear the use of Affimers with dSTORM is a viable technique to show the arrangement 
of proteins within the Z-disc and other organised structures within cells.  
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Chapter 5 - Characterising the mutations in the actin binding 
domain of α-actinin 2 associated with hypertrophic 
cardiomyopathy  
5.1 Introduction 
Familial hypertrophic cardiomyopathy (HCM) is a cardiovascular condition which could 
affect up 1 in 200 people in the population as the most prevalent genetic heart disorder 
(Maron et al. 2015). It is characterised clinically by hypertrophy of the left ventricular 
wall of the heart (thickness >13 mm). The genetic basis of the disease has been 
evaluated by the sequencing of genes encoding sarcomeric proteins, from individuals 
with HCM (Theis et al. 2006, Chiu et al. 2010, Girolami et al. 2011). From these 
studies, three point mutations located in the CH domains of α-actinin 2 have been 
identified, which may cause HCM by changing the properties of muscle α-actinins.  
The mutation A119T in the α-actinin gene 2 was identified in individuals from an 
Australian family spanning three generations (Chiu et al. 2010). 23 individuals within 
the family across all generations had the g to a missense mutation resulting in the 
A119T mutation. The A119 residue is located on helix F in the CH1 domain (Figure 
5.1A). The mutation G111V was identified in a single male individual diagnosed with 
HCM but with no prior family history of the disease (Theis et al. 2006). The G111 
residue is located on the loop between helix E and F just proceeding helix E (Figure 
5.1A). Both G111V and A119T mutations have been shown to cause reduced 
incorporation of α-actinin into the Z-discs and increased α-actinin aggregation in 
cardiomyocytes (Haywood et al. 2016). However how the mutations cause this mis-
localisation is unclear. 
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The mutation t683c (M228T) in the α-actinin gene 2 was identified in eighteen 
individuals from an Italian family spanning four generations with a range of autosomal 
dominant cardiomyopathic traits (Girolami et al. 2011). M228 is located on the loop 
between helices E and F of the CH2 domain with the residue inserted between helix A 
(CH1) and helix G (CH2), in the middle of the interface (Figure 5.1B). α-actinin 2 with 
this mutation has yet to be characterised in vitro or in vivo and therefore it is uncertain 
how the mutation contributes to the manifestation of HCM. However, mutations in α-
actinins 1 and 4 located at the CH1-CH2 interface have regularly been found to 
increase filamentous actin binding affinity (Lee et al. 2008, Weins et al. 2007, Murphy 
et al. 2016), see section 1.4.2. In the case of α-actinin 4, the mutations at the interface 
linked FSGS have been found to cause increase actin filament aggregation and α-
actinin 4 mis-localisation (Weins et al. 2007). 
The research in this chapter focusses on the three mutations located in the N-terminal 
CH domains of α-actinin 2, associated with hypertrophic cardiomyopathy; G111V, 
A119T and M228T. The effect of the mutations upon actin binding affinity were 
assessed by in vitro co-sedimentation assays of actin filaments and ABD constructs 
(19 – 269 residues) comparing the separate point mutations and the wild-type 
sequence. As M228 is located at the interface between the CH1 and CH2 domains, 
size exclusion of the M228T ABD construct was performed to determine if the “closed 
conformation” of the CH domains is altered by the methionine to threonine change.  
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5.2 Methods 
5.2.1 Introduction of M228T mutation by site directed mutagenesis (SDM) of 
muscle  
SDM was used to introduce the single point mutation, t683c (numbering using the full 
length human α-actinin 2 gene), into the cDNA sequence of wild type (WT) α-actinin 2 
ABD within the vector pGEX-6p-1 (General Methods Figure 2.1). The forward and 
reverse primers designed,                  
5’- CTGGATATTCCTAAAACGTTGGATGCTGAAGAC -3’                                                    
5’- GTCTTCAGCATCCAACGTTTTAGGAATATCCAG -3’                                                            
are complementary to the same region in the wild-type α-actinin 2 gene sequence 
(nucleotides 667-669) apart from a single nucleotide (t683c, in bold). For whole plasmid 
PCR, KOD polymerase was used as it has high fidelity and processivity. The SDM 
PCR mixture contained; 10 μL 5x KOD polymerase buffer, 1 μL dNTP (10 mM stock), 1 
μL forward primer (10 μM stock), 1 μL reverse primer (10 μM), 1 μL pGEX-6p-1 – ABD 
WT (10 ng µL-1), 1 μL KOD Hot Start DNA polymerase (1.0 unit µL-1, Merck 71086) and 
dH20 to make the final volume 50 μL. The PCR parameters using a BioRad T100 
thermocycler are as follows: Initial denaturation at 95 ºC for 1 min followed by 20 cycles 
of denaturation at 95 ºC for 50 secs, annealing at 60 ºC for 50 secs and extension 68 
ºC for 5 mins 45 secs and finished with a final extension at 68 ºC for 7 mins. 
After the PCR, the original template plasmid without the mutation was removed via a 
DpnI digest. 1 µL of DpnI (10 U µL-1, Promega R6231) was added to the PCR mixture 
and incubated at 37 °C for 2 hrs. The whole plasmid PCR product was then 
transformed into NEB 5α cells (NEB, C2987I) (General Methods 2.4) for subsequent 
minipreps (General Methods 2.5.4). The purified plasmids were then sent for 
sequencing to confirm the presence of the mutation. 
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5.2.2 Expression and purification of mutant α-actinin 2 ABD WT, G111V, 
A119T and M228T 
The construct pGEX-6p-1_ABD_M228T was generated by SDM outlined previously 
(5.2.1). The constructs pGEX-6p-1_ABD_G111V and pGEX-6p-1_ABD_A119T were 
kindly provided by Dr. Marcin Wolny. The ABD mutants were expressed using 
BL21(DE3) cells (NEB, C2527I) in 400 mL LB cultures with 0.5 mM IPTG at 37 ºC for 3 
hrs. The ABD mutants were purified by the same methods as the wild-type ABD, first 
via glutathione affinity chromatography with a precision protease incubation step and 
followed by an anion exchange chromatography step. The full protocol for the 
purification of the α-actinin 2 ABD construct (residues 19 – 269) can be found in 
section 3.2.1. The concentrations of the final 1 mL ABD mutant samples are as follows; 
ABD M228T ~ 10 µM, ABD G111V ~ 30 µM and A119T ~ 60 µM.  
5.2.3 Actin preparation and polymerisation 
Actin was purified from rabbit skeletal muscle as described in Pardee and Spudich 
1982 and stored as globular actin (G-actin, ~100 µM) at -80 ºC in G-actin buffer (20 
mM Tris–HCl, pH 8.0, 0.2 mM Na2ATP, 0.2 mM CaCl2, 0.5 mM mercaptoethanol) until 
use. For the co-sedimentation assays the G-actin was polymerised by adding 20 µL of 
exchange buffer (3 mM MgCl2, 11 mM EGTA) to 200 µL of the G-actin sample and 
incubated on ice for 15 mins. This was followed by the addition of 20 µL of 
polymerisation buffer (300 mM KCl, 120 mM MOPs, 1 mM EGTA, 12 mM MgCl2, and 1 
mM DTT pH 7.0) and a further 2 hr incubation on ice.  The filamentous actin was then 
dialysed in F-actin buffer (50 mM KCl, 10 mM MOPs, 1 mM EGTA, 1 mM MgCl2, and 1 
mM DTT pH 7.0) for 72 hrs at 4 ºC.  
5.2.4 Co-sedimentation assays of actin filaments with WT, G111V, A119T 
ABD from α-actinin 2 
In a volume of 200 µL, F-actin (5 µM) and mixtures of varying concentrations of ABD 
(2.5, 5, 10, 15, 20, 40 and 60 µM) were used. ABD samples were dialysed in F-actin 
buffer (50 mM KCl, 10 mM MOPs, 1 mM EGTA, 1 mM MgCl2, and 1 mM DTT pH 7.0) 
before use in the co-sedimentation assays. Samples were incubated at room 
temperature for 1 hour before centrifugation in Beckman Coulter ultra-centrifugation 
tubes (7 x 20 mm, 343775). Samples were then centrifuged at a high speed (100,000 
xg) in a Beckman optima TLX centrifuge (Beckman TLA100 rotor) for 1 hour at 24 oC. 
The supernatants were then carefully separated from the pelleted actin. The pellets 
were resuspended in 200 µL 1x SDS sample buffer. The supernatant protein samples 
were precipitated using trichloroacetic acid (TCA) and resuspended in 200 µL 1x SDS 
sample buffer. All samples were subsequently boiled at 100 ºC before running on a 
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SDS-PAGE. 15 µL of each sample were loaded onto 12 % acrylamide/Bis-acrylamide 
gels and the gels were stained with Coomassie Blue after the electrophoresis run. The 
software package Image-Lab (Bio-Rad) was used to perform densitometry analysis of 
the bands on the gels after imaging. Control gels of both actin and ABD at a range of 
concentrations (1 - 60 µM) were also run and analysed for normalisation of the band 
intensity values obtained. 
5.2.5 Co-sedimentation assay of actin filaments with wild-type and mutant 
M228T ABD from α-actinin 2 
Filamentous actin (10 µM) was incubated with a fixed concentration of ABD (5 µM) in 
F-actin buffer (50 mM KCl, 10 mM MOPs, 1 mM EGTA, 1 mM MgCl2, and 1 mM DTT 
pH 7.0), 200 µL volume in total. Three samples of actin with wild-type ABD were 
prepared and three with the ABD M228T mutant were prepared in Beckman Coulter 
ultra-centrifugation tubes (7 x 20 mm, 343775).  Control samples were also prepared; 
WT ABD only (5 µM), WT M228T only (5 µM) and actin only (10 µM). All samples were 
incubated at room temperature for 30 mins. Samples were then centrifuged at a high 
speed (100,000 xg) in a Beckman optima TLX centrifuge (Beckman TLA100 rotor) for 
1.5 hrs at 24 ºC. The supernatants were carefully separated from the pelleted actin. 
The pellets were resuspended in 1x SDS sample buffer and the supernatants were 
diluted (1:1 volume) in 2x SDS sample buffer. All samples were subsequently boiled at 
100 ºC before a SDS-PAGE run. 10 µL of each sample were loaded onto a Mini-
PROTEAN® TGX™ Precast 4-20 % acrylamide/Bis-acrylamide gels (Biorad, 4561095) 
and the gels were stained with Coomassie Blue after the electrophoresis run. The 
software package Image-Lab (Bio-Rad) was used for the densitometry analysis of the 
bands on the gels after imaging.  
5.2.6 Size exclusion of Wild-type and M228T α-actinin 2 ABD 
A Tricorn 10/200 gp column (GE healthcare) packed with Superdex 75 resin attached 
to an ÄKTA Prime plus system was used for the size exclusion runs. 100 µL of protein 
samples were loaded onto the column for each size exclusion run. The WT and M228T 
ABD samples (each 10 µM) were in PBS for the runs and the column was equilibrated 
in PBS. During each run the UV absorbance was measured and the elution volume 
was taken as the top of the elution peak. 
The molecular weight of the ABD species eluted off the column was estimated from 
runs using low molecular weight standards (Gel Filtration LMW Calibration Kit, GE 
healthcare, 28403841) (Figure 5.2A). The elution volumes for each protein standards 
(where the UV absorbance was highest) were recorded and the Kav was calculated.  
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Kav = (protein species elution volume – void volume) / (column volume – void volume) 
The column volume was 14.1 mL and the void volume was measured by running 
dextran blue 2000 (1 mg mL-1) down the column and recording the elution volume (5.79 
mL). The Kav values of the standards were plotted against the logMW and a standard 
curve was plotted (Figure 5.2B). Using the standard curve, the estimated MW of the 
protein samples were calculated. 
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5.3  Results  
5.3.1 Affinities of α-actinin 2 ABD mutants G111V, A119T, M228T and wild-
type to filamentous actin 
To assess how the point mutations change the binding affinity of α-actinin-2 to actin, 
co-sedimentation assays with filamentous actin and the mutant ABD constructs (ABD 
G111V and A119T) were compared to that for wild-type ABD constructs (Figure 5.3). 
For the co-sedimentation assays shown here (compared against the wild-type ABD), 
the Kd for ABD A119T increased ~2 fold and only increased by a small amount for 
ABD G111V. Neither mutant ABD showed a significant difference in affinity compared 
to the wild-type. Similar Kd values were reported in Haywood et al. 2016 using the 
results shown here and three further repeats for each construct performed separately 
by Dr. Marcin Wolny. Across all human isoforms of α-actinin the mutations G111V and 
A119T are the first reported mutations located on the CH domains not to increase the 
actin binding affinity of α-actinin.  
Due to poor expression of the ABD M228T construct, a fixed concentration of the wild-
type and the M228T construct were pelleted with filamentous actin (1:2 molar ratio) to 
and compared (Figure 5.4). Although a Kd value could not be determined, there was a 
~ 2 fold increase in the levels of ABD M228T pelleting with the actin compared to wild 
type ABD. This suggests a significant increase in actin binding affinity. This was not 
unexpected, as it follows a similar trend to that shown for other mutations at the CH1-
CH2, which also increase binding affinity to actin (Lee et al. 2008, Weins et al. 2007, 
Murphy et al. 2016) 
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5.3.2 Analytical size exclusion of the α-actinin 2 ABD mutant M228T 
Out the three known α-actinin 2 mutations located in the ABD linked to hypertrophic 
cardiomyopathy, M228T is the only mutation situated at the interface between CH1 and 
CH2 and ABD M228T has an increased affinity to actin. A conformational change from 
the closed conformation to a more extended conformation, whereby the CH1 and CH2 
disassociate from one another, is thought to occur upon actin binding (Lui et al. 2004, 
Franzot et al. 2005, Galkin et al 2010). Size exclusion chromatography was used to 
evaluate if the ABD M228T mutant population adopts a more open, extended 
conformation compared to the wild-type. The UV absorbance elution profiles of wild-
type ABD and the M228T ABD are almost identical (Figure 5.5). This suggests the 
overall conformation of the mutant construct is the same as the wild-type. It is also 
interesting to note the estimated MW for both constructs were ~ 34 kDa, an increase 
upon the real MW of 28.6 kDa similar to what was reported in section 3.3.3.  
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5.4 Discussion 
Here the ABD A119T and G111V mutants were both found to not significantly reduce 
the binding affinity to actin compared to wild-type ABD. In adult rat cardiomyocytes, a 
reduced incorporation of mutant α-actinins, G111V and A119T, into the Z-discs was 
reported (Haywood et al. 2016). As the reduced affinity to actin of the mutants was not 
significant, it was suggested that the reduced incorporation into the Z-disc might the 
result of disruption to PIP2 regulation of α-actinin (Haywood et al. 2016). The effects of 
the mutations in the CH domains upon the regulation of α-actinin 2 by PIP2 have yet to 
be explored.  
PIP2 is thought to regulate the interaction of α-actinin 2 with the Z-repeats of titin 
(Young and Gautel 2000). After analysis of the ABD α-actinin 3 crystal structure, a 
triplet of arginines on the CH2 domain were proposed to act as a binding platform on 
the CH2 for the negatively charged PIP2 head (R163, R192 and R169 on α-actinin 2) 
(Franzot et al. 2005). The mutations linked to HCM; G111V, A119T and M228T are 
not located near the arginine binding platform. Fluorescence anisotropy has been used 
with a shorter PIP2 variant (PIP2 - C6) and an α-actinin mutant construct, in which the 
triplet arginines were mutated to glutamates (Ribeiro et al. 2014). About a 50 % 
reduction in anisotropy signal was observed between the wild-type and the mutant 
construct indicating the importance of the arginines for PIP2 binding. However, binding 
was not completely ablated suggesting other residues maybe involved. The 
mechanism for PIP2 regulation has been proposed whereby the C-terminal EF 3-4 
domain binds titin when PIP2 disrupts the interaction between the EF 3-4 and the linker 
region of α-actinin (Franzot et al. 2005, Ribeiro et al. 2014). Molecular dynamic 
simulations show it is possible for the fatty acid chain of PIP2 to reach the neck region 
when bound to the CH2 domain (Ribeiro et al. 2014). The role of the CH domain 
mutations in disrupting PIP2 cannot be ruled out as the PIP2 mechanism remains 
unclear. There is also precedence for mutations in the ABD altering the regulation of 
non-muscle α-actinins. Calcium has been shown to have no effect on the full-length α-
actinin 4 affinity to actin with the K255E mutation, which is situated at the CH1-CH2 
interface (Weins et al. 2007).  
It could still be argued the mis-localisation of the α-actinin 2 mutants G111V and A119T 
outside of the Z-disc is the result solely of a weaker affinity to actin.  The residue A119 
is located on helix F of the CH1 domain. On the same helix are residues E120 and 
E121 (conserved in all isoforms of α-actinin) which have been hypothesised to form salt 
bridges with actin subunits, by molecular dynamic simulations (Shams et al. 2016). In 
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the ABD A119T crystal structure (Haywood et al. 2016, PDB code 5A4B), the T119 
residue forms a hydrogen bond with N101 on helix E. This partial anchoring of helix F 
may not allow for the optimal orientation of helix F for actin binding, resulting in its 
reduced affinity. However, the involvement of E120 and E121 at the ABD : actin cleft 
interface has not been shown experimentally. Also, the glutamate pair is not well 
conserved in the spectrin family; human utrophin, dystrophin and filamin A all have a 
threonine and an aspartate positioned on helix F instead of the glutamate pair.  
G111 is located on the loop between helix E and F, preceding helix E of the CH1 
domain. The CMPT α-actinin 1 linked mutation V105I, a mutation to a larger 
hydrophobic residue has been shown to have an increased affinity to actin, however 
the exact Kd has not been determined (Murphy et al. 2016). The helix E and F region 
is conserved in all human α-actinins and the equivalent residue to V105 in α-actinin 2 is 
V112. Having two mutations next to each other, one increasing affinity to actin (V112I) 
and the other decreasing affinity (G111V), highlights the importance of the region for 
binding actin. 
In vitro characterisation of the ABD M228T construct here has shown that this mutation 
increases binding to actin and does not result in a major change to the conformation to 
the CH domains. Single α-actinin 4 focal segmental glomerulosclerosis (FSGS) causing 
mutations at the interface have also been reported to increase the ABD affinity to actin 
whilst not changing the ABD conformation (Lee et al. 2008). It has been hypothesised 
these mutations disrupt interactions between the CH domains and lower the energy 
required for the transition between the closed and open conformations, resulting in the 
increased affinity to actin filaments.  Without a solved crystal structure of the ABD with 
the M228T mutation it is unclear if the methionine to threonine mutation disrupts 
contacts at the interface.  Further characterisation of the role of M228T in the 
manifestation of HCM is required, especially to determine how the mutant α-actinin 
localises in striated muscle and how the Z-discs are altered.  
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 Chapter 6 – Final Discussion  
6.1 Using dSTORM with PERPL analysis to study protein arrangement in 
the Z-disc 
A main objective of this project was to determine if dSTORM is a viable technique for 
determining protein arrangement of Z-disc proteins. dSTORM has the reported 
resolution (20 nm in the x,y plane, 50 nm in the z-direction) (van de Linde et al. 2011) 
and therefore has the capability to acquire localisation information for proteins within 
the Z-disc regions.  The models of the Z-discs from previous electron microscopy and 
tomography studies have yet to reach a resolution to determine the arrangement of 
most Z-disc proteins apart from the α-actinin links between actin filaments. Here, the 
dSTORM reconstructions of the cardiomyocytes labelled with either α-Affimer 9 or Z-
Affimer 12 showed localisation data within the Z-disc regions of the cardiomyocytes 
(see 4.3.1). Therefore confirming, localisation information within the Z-discs can be 
obtained using dSTORM. However, from the dSTORM reconstruction of a single field 
of view alone the arrangement of α-actinins and the Z1/Z2 domains could not be 
determined. This was for two reasons; (1) the labelling efficiency of Affimers were not 
100 % and the localisation precision of the dSTORM dataset varied (see Figure 4.2). 
Further PERPL (patterns extracted from relative positions of localisations) analysis of 
the dSTORM dataset was required to analyse the arrangement of the Z-disc proteins. 
PERPL analysis was used to analyse the distances between pairs of localisations 
(relative positions) to visualise the arrangement of proteins in vivo (see 4.2.3). 100 % 
Affimer labelling efficiency is not required and localisation datasets from different fields 
of view can be combined for PERPL analysis. Also, only localisations with a localisation 
precision of ≤ 5 nm was used for used for further PERPL analysis as common relative 
positions could be reliably observed whilst retaining a majority of the dataset. 
Studying the arrangement of α-actinins in cardiomyocytes using dSTORM with PERPL 
analysis in chapter 4 has shown it to be a promising technique for determining the 
arrangement of regularly spaced proteins in the Z-discs. The relative position density 
histogram of the α-actinin localisation dataset showed high relative position density 
(above background) in the axial direction at 18 nm. From EM studies, α-actinins are 
thought to be regularly spaced every 19.2 nm along the actin filament in the axial 
direction. The arrangement of α-actinins observed from EM studies and the 
arrangement observed by dSTORM with PERPL analysis are within ~ 1 nm of each 
other. Also, the PERPL analysis of the α-actinin dSTORM dataset suggests regular 
spacing of 20 nm in the transverse plane. Previous EM studies have put the lattice 
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spacing of the Z-disc in the small square lattice conformation at ~ 20 nm (Goldstein et 
al. 1989). It can be suggested the arrangement of α-actinin actin binding domains 
bound to actin also follow the lattice spacing of 20 nm from the final RPD histogram.  
However, this technique can be improved upon to better show arrangement of proteins 
in densely packed Z-disc regions. It can be argued larger dSTORM localisation 
datasets, than those used in chapter 4, are required. In chapter 4 the 1D RPD axial 
profile generated from the α-actinin localisation dataset did show the repeat spacing of 
18 nm, with three distinct peaks above background (see Figure 4.4B). However, five 
peaks of high RPD above background representing the spacing between six layers of 
α-actinin bound to actin were expected in the 1D axial profile. This could be the result 
of having fewer relative positions between the α-actinins spaced further apart in the 
dataset. This is one case where more prominent common relative positions in the 
dataset are more easily observed above background in the final RPD histogram than 
other less prominent common relative positions. Therefore, the less prominent relative 
positions will only be seen in the final RPD histogram when using a larger dataset. 
It can also be argued to better show the regular arrangement of proteins in the Z-disc, 
the localisation precision cap of the dSTORM dataset for PERPL analysis should be 
lowered below 5 nm. Using a 5 nm localisation precision cut-off, the repeat 18 nm 
spacing of α-actinins was observed in the axial direction. Also, in the case of the Z1/Z2 
domains localisation dataset a regular 25 nm spacing was observed in the transverse 
plane (see Figure 4.6B). The two cases of using PERPL analysis in chapter 4 shows 
for the study of proteins regularly space ~ 20 nm or more apart, a localisation precision 
maximum of 5 nm is sufficient. However, there are limitations in the PERPL analysis 
when using a 5 nm localisation precision cut-off.  If the proteins of interest are arranged 
less than 5 nm apart from each other, the arrangement may not be seen in the final 
RPD histogram. For example, a high RPD representing the spacing between a pair of 
ABD in the same layer (~ 2.74 nm, Figure 4.4B) was not seen in the α-actinin RPD 
histogram (in the axial direction). Also, if the proteins of interest have different spacing 
of a similar distance (within 5 nm of each other), the different spacing may not be 
distinct from one another in the final RPD histogram. For example, a high RPD at ~ 10 
nm in the transverse plane of the α-actinin RPD histogram. This may correspond to 
both the spacing of actin binding domains in a single α-actinin layer bound to the same 
actin filament and the spacing of actin binding domains bound to adjacent actin 
filaments because they are thought to be similar distances. It is also known the Z-discs 
has two different lattice conformations, the basket weave and small-square lattice, with 
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different lattice spacing. The α-actinin transverse plane RPD did not suggest the 
presence of two different lattice spacings, only a 20 nm spacing. Lowering the 
localisation precision cap may also reduce the background in the final RPD histogram. 
A high RPD background could be seen in the α-actinin RPD histogram (Figure 4.4A). 
The background could be attributed to mis-localisation of the Affimer, auto-
fluorescence of the cardiomyocyte and poor localisation precision of the dataset. 
Therefore, the background seen in the α-actinin RPD histogram could be reduced by 
lowering the localisation precision cut-off. Lowering the localisation precision cut-off 
would however reduce the number of usable localisations for PERPL analysis. 
Therefore, again a larger localisation dataset would be required. To generate the 
dSTORM localisation dataset required many fields of view of labelled cardiomyocytes 
would need to be imaged and combined for PERPL analysis.  
6.2 Using other microscopic techniques for studying the arrangement of 
Z-disc proteins 
6.2.1 Multi-colour dSTORM 
In the future, multi-colour dSTORM (van der Linde et al. 2009) with PERPL analysis 
can be used to obtain localisation information of two different Z-discs protein within the 
same cell. Interpretation of the final RPD histogram from single colour dSTORM to 
understand the arrangement of a specific protein can be difficult.  For example, in 
chapter 4 the spacing of α-actinin in the transverse planes was shown to be ~ 20 nm 
which was thought to follow the actin filament lattice spacing in the Z-discs. Whilst the 
spacing in the transverse planes of the Z1/Z2 domains was shown to be ~ 25 nm. It is 
unclear if the Z1/Z2 domains have a different spacing to the actin filament lattice 
spacing or the difference observed is due to the cell variation or the small Z1/Z2 
domains localisation dataset used. As discussed in chapter 4, the actin capping protein 
CapZ would be a good candidate protein for studying the lattice spacing. Multi-colour 
dSTORM can be used to obtain localisation information for the CapZ protein and either 
α-actinins or the Z1/Z2 domains from the same cardiomyocyte. The comparison of the 
arrangement of CapZ with the arrangement of either α-actinin or the Z1/Z2 domains 
can determine if these proteins are following the actin lattice spacing. Likewise, multi-
colour dSTORM can be used to obtain localisation information for α-actinins and the 
Z1/Z2 domains in the same cell to compare the transverse spacing of the two proteins. 
The main disadvantage of this technique is that to discount any cellular variation only 
the localisation information from a single field of view could be used. This would limit 
the size of the dataset used for PERPL analysis. The labelling efficiency of the 
molecular probes (e.g. Affimers) would be required to be high.  Also, different 
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molecular probes and fluorescent dyes would be used for each target protein. As a 
result, the size of the localisation datasets to be compared by PERPL analysis would 
be different. If the datasets are significantly different they cannot be reliably compared.  
6.2.2 Photoactivated localisation microscopy 
Photoactivated localisation microscopy (PALM) is another viable super-resolution 
fluorescence microscopy technique to use to study the arrangement of proteins in vivo. 
The single molecule localisation principle of PALM is the same as dSTORM however 
PALM imaging uses photo-switchable fluorescent fusion proteins (Betzig et al. 2006) 
instead of stochastically activated fluorescent dyes. Therefore, PALM can also be used 
to gain localisation information within the Z-discs which can be used for further PERPL 
analysis. It can be argued dSTORM is the more suitable technique for studying Z-disc 
protein arrangement. From using dSTORM to study the arrangement of α-actinins and 
Z1/Z2 domains, it is clear having a high localisation precision dataset is vital for 
determining the arrangement of closely spaced Z-disc proteins. Localisation precision 
is dependent upon the number of photons emitted from a fluorophore (see 4.2.3). 
Fluorescent fusion proteins emit fewer photons than commercially available fluorescent 
dyes (Moerner 2012) and therefore the localisation precision for a PALM localisation 
dataset would be lower compared to a dSTORM localisation dataset.  
6.2.3 Electron tomography 
The resolution of the current models of the Z-disc generated by EM generated have yet 
to reach a resolution to determine the arrangement of most Z-disc proteins. The most 
recent model of the Z-disc small square lattice structure generated by electron 
tomography with sub-tomographic averaging came to an 8 nm resolution (Burgoyne et 
al. 2015). However, with the advancement in electron microscopes, detection and 
image processing it is now possible to produce higher resolution models by electron 
tomography.  Whether models of the Z-disc generated can reach a resolution so that 
density in the model can be identified as specific Z-disc proteins, remains to be seen. 
Also, sub-tomographic averaging would be required to generate a high-resolution 
model with the assumption all the sub-tomographs are homogenous. Therefore, any 
variation between sub-tomograms would be lost. As shown with α-actinin arrangement 
in chapter 4, electron tomography and super-resolution fluorescence microscopy can 
be used in tandem with each other to support and verify any Z-disc arrangements 
concluded by either technique. 
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6.3 Using dSTORM and PERPL analysis to study protein arrangement in 
other cellular structures 
The work in chapter 4 has shown the capability of dSTORM with PERPL analysis to 
study the arrangement of Z-disc proteins in cardiomyocytes. However, dSTORM with 
PERPL analysis is not limited to the study of the arrangement of Z-disc proteins and 
can be used to study the arrangement of other regularly spaced protein in vivo. As 
shown in chapter 4, PERPL analysis is highly suited to study the arrangement of 
proteins in striated muscle cells. The cytoskeleton throughout striated muscle cells is 
highly ordered with bundles of myofibrils running the length of the cell. Therefore, all 
the localisation information throughout the cell can be used and localisation information 
from different cells can be easily combined by aligning the dSTORM reconstructions. 
(see methods 4.2.3). The same methodology shown in chapter 4 can also be used to 
study the arrangement proteins in other regions of the sarcomeres within striated 
muscle cells. 
The cytoskeleton structures of other cell types are not as highly organised as striated 
muscles cells. However highly ordered sub-cytoskeletal structures have been reported, 
for example the microtubule assembly of primary cilia, and PERPL analysis can also be 
used to study protein arrangement within these sub-structures. In these cases, 
however dSTORM data collection and PERPL analysis could be more time consuming 
compared with using the techniques to study Z-disc protein arrangement. As the 
localisation collected during dSTORM imaging are confined to sub-structures more 
fields of may need to be imaged to be collect enough localisation data for reliable 
PERPL analysis. Also, rather aligning the whole cell for the combination of localisation 
dataset each sub-cytoskeletal structure would need to be individually aligned.  
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6.4 Affimers as molecular probes for super-resolution fluorescent 
microscopy 
6.4.1 Using α-Affimer 9 and Z-Affimer 12 to label cardiomyocytes for 
dSTORM imaging shows the potential of Affimers for super-resolution 
imaging 
Another objective of this project was to determine if Affimers are a viable option as 
molecular probes for super-resolution fluorescent microscopy. One advantage of using 
Affimers as molecular probes over immunoglobin based probes such as antibodies and 
nanobodies is the fast generation of Affimers which can bind specific targets. Using a 
phage display assay with an Affimer phage library allows for the fast generation of 
specific Affimer binders. Using this approach eight unique Affimer binder sequences for 
the ABD of α-actinin and seven Affimer sequences for the Z1/Z2 domains of titin were 
generated in this project. However, it is uncertain if the Affimer binders can be reliably 
generated by the in vitro phage display assay to be used as molecular probes in vivo. 
However, in this work three of the eight α-Affimers and four of the seven Z-Affimers 
were found to bind their target in vivo. Therefore, in the future there is promise that 
Affimers generated to bind other Z-disc proteins by phage display assays can be used 
as molecular probes for fluorescence microscopy. 
Another key advantage over of Affimers over other molecular probes available is their 
small size (~ 12.5 kDa, ~ 3 nm in linkage error). It can be suggested that because of 
the size of the Affimers, they are more capable of penetrating dense networks of 
proteins than larger molecular probes, such as antibodies. In this project dSTORM 
imaging of the cardiomyocytes labelled with α-Affimer 9 and Z-Affimer 12 showed 
localisations throughout the densely packed Z-disc regions. Further PERPL analysis of 
localisation information from cardiomyocytes labelled with α-Affimer 9 and Z-Affimer 12 
suggest a high labelling efficiency of the Affimers. The 1D relative position density 
profile in the axial direction from a α-Affimer 9 labelled cardiomyocyte (single field of 
view FOV1, Figure 4.5A) showed five peaks above background. This suggest that α-
Affimer 9 was capable of binding all six α-actinin layers bound to actin in the Z-discs. 
Likewise, the regular 25 nm spacing observed in the transverse planes 1D RPD profile 
from a single Z-Affimer 12 labelled cardiomyocyte (FOV 2, Figure 4.7B) suggests 
ahigh labelling efficiency of Z-Affimer 12. dSTORM imaging of cardiomyocytes with 
PERPL analysis has shown the capability of Affimers to bind their respective targets in 
the dense Z-disc network.  
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For super-resolution fluorescence imaging Affimers are the preferred molecular probes 
to antibodies due to their smaller size. However, the same dSTORM imaging of 
cardiomyocytes labelled with antibodies generated to bind the same Z-disc proteins 
has yet to be performed. Without direct comparison of the different probes it cannot be 
determined if Affimers have a better labelling efficiency than antibodies in the Z-discs. 
Also, as discussed in the previous section (6.1) large dSTORM localisation datasets 
are required for PERPL analysis, therefore a high labelling efficiency of the Affimer in 
vivo is also required. A factor that can affect the labelling efficiency of an Affimer is the 
binding affinity of the Affimer to the target. As shown in chapter 3, the considerations in 
choosing α-Affimer 9 and Z-Affimer 12 for dSTORM imaging compared to the other 
candidates generated were: (1) If they could localise to the Z-discs in vivo and (2) the 
stoichiometry of the Affimers bound to their respective targets (by size exclusion). The 
binding affinity of the Affimers to their respective targets were not determined and were 
not a factor when the Affimers were chosen. In the future the binding affinities of α-
Affimer 9 and Z-Affimer 12 should be determined, for example by isothermal 
calorimetry. Also, for future Affimers generated the binding affinities should be 
accessed before use as molecular probes to determine the best Affimer candidate. 
6.4.2 Non-immunoglobulin binding protein alternatives as molecular probes 
for dSTORM 
In this work it has been shown that Affimers are a promising alternative to antibodies 
for super-resolution fluorescence microscopy.  There are other small non-
immunoglobulin scaffold proteins available which can also be as molecular probes for 
super-resolution microscopy (reviewed in Bedford et al. 2017). Like Affimers, to be 
used as molecular probes they are required to be small for a reduced linkage error and 
are capable of binding their targets in vivo. As non-immunoglobulin scaffold proteins 
they would also be quick and inexpensive to produce. Two examples of small scaffold 
proteins which meet the criteria are Affibodies and Monobodies. Affibodies are the 
single 3-bundle helix “Z-domain” of immunoglobulin binding staphyloccal protein A with 
the residues involved in Fc binding altered to bind other target proteins (Nord et al. 
1997). They are highly soluble, stable and they have no cysteines present in the 
sequence. Also, an anti-HER2 affibody has been used to visualise the localisation of 
HER2 (a transmembrane receptor tyrosine kinase) in SKBR3 breast cancer cell by 
fluorescence microscopy (Peckys et al. 2015). Affibodies (58 residues, ~ 6 kDa) (Nord 
et al. 1998) are smaller than Affimers (~12.5 kDa) and therefore would have a reduced 
“linkage error” and would more easily penetrate dense cytoskeleton networks. 
Affibodies have two binding sites; one on the surface of helix one (7 residues) and the 
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other on helix two (6 residues). One advantage of Affimers over Affibodies is that the 
variable binding loops are separate from the scaffold backbone and therefore variable 
binding residues are less likely to affect the stability of scaffold. Also, the binding loops 
of Affimers (each 8/9 residues) (Tiede et al. 2014) are larger than the variable binding 
regions of Affibodies (13 residues), therefore a more diverse range of Affimers 
generated to bind a specific target.  
Monobodies are based on the 10th fibronectin type 3 domain with a scaffold of seven β-
strands and three binding loops (each ~ 5 residues) (Koide et al. 1998). Monobodies 
(94 residues, ~10 kDa) are of a similar size to Affimers, highly soluble, highly stable 
and they have no cysteines present in the sequence. Also, an anti-EphA2 Monobody 
has been used to visualise the localisation of EphA2 (a marker protein for various 
tumours) in vivo by fluorescence microscopy (Park et al. 2015). Monobodies have two 
different phage libraries; one where there is variability in the binding loops only (Koide 
et al. 1998) and another where there are also two variable binding sites (~ 3 residues) 
at the ends of the β-strands next to two of the binding loops (Koide et al. 2012). With 
two different binding libraries a more diverse range of Monobodies can be generated to 
bind a specific target, compared to other scaffold proteins such as Affimers. 
6.5 The role of HCM mutations G111V, A119T and M228T in disrupting α-
actinin 2 function in the Z-discs 
In chapter 5 three mutations linked to hypertrophic cardiomyopathy (HCM), located 
within the actin binding domain (ABD) of α-actinin 2, were studied to see the mutations 
effect on the ABD affinity to filamentous actin. Compared to the ABD wildtype, the 
mutants G111V and A119T showed no significant change in actin affinity (see 5.3.1). 
However, the mutations G111V and A119T respectively have been found to cause α-
actinin 2 mis-localisation in vivo (Haywood et al. 2016). Therefore, the mutations must 
disrupt the interaction between another binding partner of the ABD. It has been 
suggested the mutations may disrupt PIP2 regulation of α-actinin 2, as PIP2 is known to 
interact with the ABD (Fukami et al. 1996, Ribeiro et al. 2014).  Therefore, the next 
step would be to determine if mutations G111V and A119T disrupts the interaction 
between PIP2 and the ABD. The main binding site for the PIP2 has been proposed to be 
a triplet of arginines (R163, R192 and R169) on the CH2 domain (Franzot et al. 2005) 
and the importance of these residues for PIP2 binding has been verified by 
fluorescence anisotrophy (Ribeiro et al. 2014). A similar experiment can be used to 
determine if the mutant ABD constructs perturb the ABD : PIP2  interaction.  If it is 
found that the mutations do not disrupt the PIP2 interaction, the mutations may disrupt 
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the binding of another unknown binding partner of the ABD resulting in the mis-
localisation in vivo observed. 
The mutation M228T on the other hand was shown to significantly increase the affinity 
of the ABD to filamentous actin compared to the wild type construct (see 5.3.1). As 
discussed in Chapter 5 the M228 residue is located at the interface between the two 
calponin homology (CH) domains. Many other mutations (linked to disease in non-
muscle α-actinins 1 and 4) are also located at the interface between the CH domains 
and have been shown to increase the binding affinity of the ABD to actin (see 1.3.2). It 
has been hypothesised (for α-actinin 4 mutations) the mutations cause the increased 
binding affinity as they disrupt contacts between the two CH domains and reduce the 
energy required for CH domain separation (Lee et al. 2008).  M228 within the CH2 
domain does not lie in any known actin binding site therefore it can be suggested, the 
increase binding affinity of the M228T ABD is also due to the disruption of contacts at 
the interface.  
However, the actin binding ABD mechanism and the role of the CH2 domain, where 
M228 resides, is currently unclear. Previous AUC experiments of the wild type α-actinin 
4 ABD have suggested the CH domains to be in a compact closed conformation when 
free in solution. This suggests the ABD initially binds to actin in a closed conformation. 
Here, size exclusion of the wild-type and M228T ABD α-actinin 2 constructs however 
suggests the ABD may be in a more open conformation when free in solution than 
previously thought. Further experimentation, such as AUC, is required to better analyse 
the conformation of the ABD from α-actinin 2 when free in solution. However, this 
suggests the ABD may be required to be in an open conformation to initially bind actin. 
Also, as there was no difference between wild-type and M228T constructs it can be 
argued the M228T does not play a role in disrupting contacts at the interface between 
CH domains. The highest resolution EM model (16 Å) of the α-actinin CH domains 
(Galkin et al. 2010) suggests in the final bound state the CH domains are in an open 
conformation with the CH1 domain bound to the filament and the CH2 either unbound 
to the filament or only very weak binding. This is further supported by a high-resolution 
model of the filamin A CH domains bound to actin (Iwamoto et al. 2018, 3.6 Å) which 
shows the ABD in an open conformation and the CH2 domain unbound to the actin 
filament. The ABD being in a final open state with the CH2 domain unbound to actin 
supports the hypothesis the mutation M228T increases binding affinity by lowering the 
energy required for the transition from a closed to an open conformation. As the role of 
the CH2 during the ABD binding mechanism is unclear the role of the M228 residue 
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also is unclear. To better understand the how the ABD of α-actinin interacts with actin 
and the role of the CH2 domain a high-resolution model of the CH domains bound to 
actin is required. As shown by the model of the CH domains of filamin A bound to actin 
(Iwamoto et al. 2018), a high-resolution model can be generated by electron 
microscopy. A model of the CH domain with the M228T mutation can also be 
generated to determine if the mutation alters the conformation of the final bound state.  
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